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1. Abstract 
 
Inhibitory transmission plays a major role in information processing in the brain since 
it integrates excitatory signals and defines the gain between neural input and output.  
γ-Amino butyric acid (GABA) is the main inhibitory neurotransmitter in the adult 
mammalian brain. By activating GABAA and GABAB receptors this neurotransmitter 
inhibits neuronal firing and stabilizes the membrane potential near the resting value. 
In particular GABAA receptors are permeable to chloride ions and are responsible for 
phasic and tonic hyperpolarizing responses. GABA-mediated currents are the result of 
rapid, sequential events including transmitter release from the presynaptic terminal, 
transmitter diffusion within and outside the cleft and post-synaptic receptors gating. 
The kinetics of each of these processes is crucial in determining the shape of post-
synaptic currents. Therefore the modulation of any of these events leads to the 
heterogeneity of GABAergic responses and to changes in the potency of inhibition. 
In this thesis I have studied the sources of such variability at presynaptic/cleft and 
postsynaptic level. At presynaptic/cleft level I have focused on the influence of the 
agonist concentration profile in the synaptic cleft on GABA-mediated synaptic 
currents. Fast-off competitive antagonists and computer simulations allowed 
estimating the range of variability of the peak concentration and the speed of GABA 
clearance form the synaptic cleft. At postsynaptic level particular attention has been 
attributed to the impact of GABAA receptors clustering on both phasic and tonic 
GABAA-mediated inhibition.  With ultrafast applications of GABA and computer 
simulations it was possible to describe the modulation of GABAA receptor gating 
induced by clustering.  
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2. Introduction 
2.1 Discovery of GABA as inhibitory neurotransmitter 
The biochemical identification of GABA dates back to 1949 when the biochemist 
Eugene Roberts was performing ninhydrin-based chromatographic quantifications of 
the free amino acid content in the mouse brain. He found by chance an unidentified 
and previously unobserved ninhydrin-positive compound, which later proved to be 
GABA (Roberts & Frankel, 1950; Awapara et al., 1950). A further and absolute 
characterization of GABA came from Udenfriend (1950) with the isotope-derivative 
method he had developed. The careful and dedicated work of Roberts and colleagues 
lead to a thorough analysis of GABA metabolism (Roberts et al., 1960). In particular 
it was found that in the nervous tissue GABA is mainly synthesized from glutamate 
by glutamic acid decarboxylase (GAD) and it is degradated by GABA transaminase to 
glutamate and succinic semialdehyde (SSA), the latter being rapidly converted to 
succinate. 
Only several years after the biochemical identification of GABA, came its functional 
characterization. The first suggestion that GABA might have an inhibitory function in 
the vertebrate nervous system came from studies in which it was found that topically 
applied solutions of GABA exerted inhibitory effects on electrical activity in the brain 
(Hayashi & Suhara, 1956). Definitive evidence for an inhibitory function of GABA 
came from the finding that GABA increases the membrane conductance by opening 
chloride channels (Krnjevic & Schwartz, 1966) and from the identification of the 
hyperpolarizing effect of GABA through an influx of Cl- ions (ten Bruggencate & 
Engberg, 1971) in different species and brain regions. 
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2.2 GABAergic transmission 
Synaptic signaling in the central nervous system is the final result of the 
counterbalance between excitatory and inhibitory stimuli. In particular the inhibitory 
system is devoted to tune the excitability of the cells either by shifting the resting 
potential towards more negative values or by lowering the cell membrane resistance. 
An inhibitory current can be elicited by the inflow of negative charged ions or by the 
outflow of positive charges through ligand- or voltage-activated channels. 
In the adult brain GABA is the main inhibitory neurotransmitter (Sivilotti & Nistri, 
1991; Kaila, 1994). GABA is synthesized in the presynaptic terminals from glutamate 
through a catabolic process catalyzed by two glutamic acid decarboxylases (GAD), 
namely GAD65 and GAD67 (Erlander et al., 1991). GABA is then loaded into 
synaptic vesicles by the vesicular inhibitory aminoacid transporter VIAAT (Gasnier, 
2000) from which it can be released upon nerve stimulation. Once released through 
calcium-dependent exocytosis, GABA activates ionotropic Cl- permeable channels 
(GABAA receptors) (Bormann et al., 1987; Schofield et al., 1987; Polenzani et al., 
1991) and metabotropic G-coupled receptors (GABAB receptors) (Wilkin et al., 1981; 
Kaupmann et al., 1997), which in turn indirectly increase K+ currents (Gage, 1992; 
Mott & Lewis, 1994; Misgeld et al., 1995) and/or reduce voltage-sensitive Ca2+ 
currents (Kamatchi & Ticku, 1990). GABA is cleared from the synaptic cleft by the 
uptake of specific transporters (GAT) located at nerve terminals and at glial cells 
(Cherubini & Conti, 2001). Thereafter GABA is finally metabolized by 
transamination of GABA-T (Roberts, 1988). 
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GABAB autoreceptors located at presynaptic terminal are thought to contribute to a 
fine control of GABA-mediated inhibition through a negative feedback on the release 
machinery (Thompson & Gahwiler, 1989; Misgeld et al., 1995; Jarolimek & Misgeld, 
1997). 
On the contrary GABAA receptors are mainly expressed on postsynaptic neurons, 
although they have been recently supposed to be present also at presynaptic sites 
(Ruiz et al., 2003). In fact action potentials evoked with antidromic stimulation of 
mossy fibers are sensitive to muscimol application, thus suggesting that presynaptic 
GABAA receptors contribute to regulating neuronal excitability. Depending on the 
concentration of GABA they see and on the duration of the exposure, these ionotropic 
receptors can elicit either phasic or tonic currents. The main differences between these 
two forms of GABA-mediated inhibition basically are the duration and the amplitude 
of the currents. Several drugs have been identified in order to pharmacologically 
distinguish them (Bai et al., 2001; Stell & Mody, 2002). However, although for sake 
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of clarity phasic and tonic currents are usually described separately, they are tightly 
related and mutually influenced.  
 
2.2.1 Phasic GABAergic currents 
Phasic GABAergic activity (synaptic transmission) is a point-to-point inhibition 
consisting of a series of anionic mediated currents, namely inhibitory postsynaptic 
currents (IPSCs), that, after reaching a peak in less than 1 ms, decay in tens of 
milliseconds. These currents result from the release of GABA-containing vesicles and 
the subsequent activation of synaptic GABAA receptors located opposite the release 
site.  
Peculiar characteristics of this fast form of transmission are the high concentration of 
agonist available to activate the receptors (in the submillimolar range) and the 
extremely brief time of exposure of the receptors to GABA (hundreds of 
microseconds). Direct consequences are that the receptors are activated in strong non-
equilibrium conditions, usually at subsaturating level, for short periods of time before 
becoming available again for subsequent activation. The presence of clusters of 
GABAA receptors opposite the release site is an essential requirement to guarantee 
efficient synaptic inhibitory transmission. 
The variability of phasic synaptic currents depends on several parameters occurring at 
different levels. Basically it is possible to distinguish between presynaptic/cleft and 
postsynaptic levels. At presynaptic level neurotransmitter release is assumed to be 
mainly a “quantal” process (Jonas et al., 1993; Jack et al., 1994; Edwards et al., 
1990). This means that neurotransmitter is released from presynaptic terminals in 
discrete units thought to be equal to the amount of neurotransmitter packed within a 
single presynaptic vesicle (the so-called “quanta”) (Katz, 1969). Assuming that the 
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release of a single quantum elicits a unitary current (quantal size, q), the amplitude of 
synaptic currents should vary as multiples of quantal size. However, large variability 
has been found in synaptic currents. This is due to many other parameters included in 
the “quantal theory of release” proposed by Del Castillo & Katz (1954), such as the 
probability of release (p), the number of release sites (n). Moreover many other 
parameters can represent presynaptic sources of synaptic variability, such as the 
concentration of neurotransmitter in the vesicles, the size and the number of vesicles 
released and the kinetics of release mechanisms. Nevertheless, structural and 
molecular features of the release site could influence synaptic currents as well. 
Among them it is worth mentioning the number and type of Ca2+ channels, their 
localization respect to the vesicles, presynaptic proteins that allow the vesicles to be 
released (vesicle priming). Once the transmitter is released in the cleft, different 
processes (i.e., diffusion of transmitter molecules and uptake) and the synapse 
geometry can influence its the concentration profile in the cleft and consequently 
synaptic currents (Atwood & Karunanithi, 2002).  
At postsynaptic level morphological, electrical and chemical features can relevantly 
provide further sources of variability of synaptic currents. In fact the number, 
localization, type, affinity and gating properties of postsynaptic receptors in addition 
to stochastic channel gating, can provide different responses to the same quantum.  
Postsynaptic determination of quantal size relies on the variability of the receptor 
number and properties. At a single synapse, if the number of receptors is limited, then 
the transmitter content of a vesicle could saturate them. Therefore any change in 
vesicular content would not be detected, so quantal size would only reflect 
postsynaptic parameters. On the contrary, at non saturated synapses, when receptor 
availability is not a limiting factor, quantal size is mainly dependent on presynaptic 
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factors (e.g., the amount of transmitter released from the vesicle, that rate at which it 
leaves the vesicle) (Atwood & Karunanithi, 2002) (see also paragraph 2.5.1). 
These topics will be described in details in the next paragraphs and will be 
implemented with the experimental results reported in this thesis. 
 
2.2.2 Tonic GABAergic inhibition 
Tonic inhibition includes tonic currents and shunting inhibition. Tonic current is a 
persistent inhibitory conductance due to the activation of extrasynaptic GABAA 
receptors continuously exposed to submicromolar concentrations of GABA. From the 
Ohm’s law it is rather intuitive that continuous activation of anionic channels leads to 
a decrease of the membrane resistance (shunting inhibition) thus reducing the gain 
between neural input and output (Blomfield, 1974). 
The concentration of GABA that elicits tonic inhibition is at least three order of 
magnitude lower than that responsible for phasic transmission and it is called 
“ambient GABA” since it represents the amount of neurotransmitter present in the 
extracellular space. Ambient GABA originates from spillover of the neurotransmitter 
released at neighboring synapses (Brickley et al., 1996; Mitchell & Silver, 2000; 
Hamann et al., 2002), from astrocytes (Liu et al., 2000; Schousboe, 2003) or from 
non-vesicular release (Attwell et al., 1993; Wu et al., 2001). For instance it has been 
demonstrated that rat hippocampal neurons co-cultured on a monolayer of astrocytes 
or exposed to astrocyte-conditioned medium exhibit larger bicuculline-sensitive 
currents than control neurons, demonstrating that GABA is actually released from 
astrocytes (Liu et al., 1996; Liu et al., 1997; Liu et al., 2000). Further sources of 
GABA can be the reverse operation of GABA transporters, also known as non-
vesicular release (Attwell et al., 1993). In fact GABA transporters on surrounding 
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neurons and/or glia can reverse either in physiological or pathological conditions 
upon increase in the cytosolic concentration of GABA or mild depolarization (Wu et 
al., 2001; Wu et al., 2003). Moreover, the efficiency of GABA reuptake system 
contributes to regulating the concentration of ambient GABA (Isaacson et al., 1993; 
Semyanov et al., 2003; Jensen et al., 2003). 
It is almost widely accepted that tonic inhibition is mainly mediated by extrasynaptic 
receptors, thus they act as high affinity sensors for ambient GABA. In fact the 
contribution of synaptic receptors to tonic currents can be almost excluded, since the 
number of extrasynaptic receptors largely exceeds that of synaptic ones (Nusser et al., 
1995; Banks & Pearce, 2000). Moreover, synaptic receptors would be less exposed to 
ambient GABA since their location within the cleft should hinder spillover. 
 
 
2.3 Presynaptic modulation of synaptic transmission 
At presynaptic level the concentration of transmitter in the cleft promptly increases 
after exocytosis, reaches a maximum value (peak) and quickly decreases (clearance). 
These factors in turn reflect the mechanisms of exocytosis, the number and the 
content of the vesicles released and the diffusion process across the cleft. 
 
2.3.1 Mechanisms of exocytosis 
For many years exocytosis has been supposed to consist of the collapse of the vesicle 
into the presynaptic plasma membrane and consequent immediate dump of 
neurotransmitter in the cleft. In the late ‘70s the immediate dump hypothesis was 
regarded as an oversimplification of exocytosis. In fact an alternative mechanisms 
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implying the formation of a fusion pore connecting the vesicle lumen with the 
synaptic cleft was proposed (Chi et al., 1976). After the tethering or docking of the 
vesicles to the appropriate presynaptic site, the exocytotic event basically occurs in 
two steps, i.e. the formation of a narrow fusion pore persisting for a variable time 
(priming) and the subsequent rapid expansion of the fusion pore that leads to the 
complete fusion of the synaptic vesicle with the presynaptic terminal (Breckenridge & 
Almers, 1987). These two steps are kinetically separated. The kinetic behavior of the 
exocytotic process can be described by a Markovian scheme, including a fusion pore 
closed state (C), open state (O) and a dilation state (D) (Wang et al., 2001). 
C O
ka kd
kc
ko
D
 
(1) 
The rates of the transitions between different states are defined by the rate constants 
ka, ko, kc and kd. The kinetics of the fusion pore can be described by its flickering 
between the closed and open state (allowing a partial release of neurotransmitter) 
before its dilation leads to the complete release of the vesicle content (Alvarez et al., 
1993). Since the transmitter can be released through the fusion pore, the rate at which 
the transmitter is released in the cleft is strongly dependent on the persistence of the 
fusion pore before its dilation. If the fusion pore persists for a relatively long time, the 
whole content of the vesicle will be released through a narrow fusion pore at a 
relatively low rate (continuous release). Otherwise, if the fusion pore quickly 
undergoes dilation, the rate of release will be much faster (instantaneous release) 
(Kleinle et al., 1996). It has been found that a threshold exists for discriminating 
between the flickering and the dilating behavior of the fusion pore (Albillos et al., 
1997). In fact a stable fusion pore can exist only below a critical pore size.  Below this 
critical value the pore is able to fully close and re-open, while at pore size larger than 
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the critical value the pore expands quickly and irreversibly (Lollike et al., 1998). This 
critical value has been estimated in chromaffin cells to be ~ 3 nm (Albillos et al., 
1997). 
Different approaches have been developed to correlate the fusion process and the rate 
of efflux of the transmitter during exocytosis (Lindau & Alvarez, 2003; Westerink, 
2004). For technical reasons, most of the experiments addressing this issue have been 
performed in non-neuronal secretory cells such as neutrophil, chromaffin cells, mast 
cells since they bear large secretory granules (Alvarez et al., 1993; Lollike et al., 
1995; Leszczyszyn et al., 1990; Lollike & Lindau, 1999). It has been assumed that the 
basic mechanisms of exocytosis in these cell types are similar to those occurring in 
neurons as several proteins involved in the exocytotic machinery in non-neuronal 
secretory cells are also present in neurons (Li & Chin, 2003; Rothman, 1994; Jahn & 
Sudhof, 1999). One approach to follow neurotransmitter release is measuring the 
capacitance of the presynaptic cell membrane (Gillis, 1995). In fact during exocytosis 
the vesicles are fused with the plasma membrane resulting in an increased membrane 
area, which can be resolved as an increase in the capacitance. Although this technique 
allows estimating the overall neurotransmitter released, it does not clarify the amount 
released per vesicle. An alternative approach to investigate single vesicle release is 
amperometry (Chow & von Ru¨den, 1995; Chow et al., 1992; Wightman et al., 1991). 
Briefly, a carbon fiber microelectrode is placed against the surface of a secretory cell 
in order to oxidize the neurotransmitter molecules (provided that they must be 
electron donor – e.g. catecholamine and serotonin). In this way when exocytosis 
occurs, the transfer of electrons during the oxidation of the secreted neurotransmitter 
can be recorded as an electrochemical current. During the exocytotic event, the 
amperometric signal shows a slight increase (foot) followed by a large spike. 
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According to the kinetic model (1), the increase of the amperometric signal before the 
spike (foot) is due to the transmitter released through the fusion pore and corresponds 
to the open state (O) (Alvarez et al., 1993). The subsequent large amperometric spike 
is ascribed to the irreversible full fusion of the vesicle with the plasma membrane and 
corresponds to the dilation state (D). Occasionally, the fusion pore can persist for a 
time sufficient to allow the complete release of the vesicle content without full fusion 
of the vesicle (Albillos et al., 1997). Furthermore imaging techniques have been 
developed to follow the fate of the vesicles during exocytosis. In recent years a 
number of specific dyes such as membrane-fluorescent styryl dyes (belonging to the 
FM dyes family) with different kinetics of dissociation from the membrane have been 
used to distinguish between the complete or incomplete depletion of synaptic vesicles 
(Aravanis et al., 2003a; Aravanis et al., 2003b). Moreover the question if transmitter 
release from synaptic vesicles is associated with full incorporation of the vesicle into 
the plasma membrane or if only a transient fusion pore is formed under physiological 
conditions has been controversial for many years (Heuser & Reese, 1973; Ceccarelli 
et al., 1972; Ceccarelli et al., 1973). Full fusion means that, following its formation, 
the fusion pore irreversibly expands to a large size and the vesicle membrane collapse 
into the plasma membrane. Transient fusion (usually also referred as “kiss-and-run”) 
means that the pore opens and possibly expands, but then closes again such that the 
vesicle retains its integrity when it discharges its content (Klingauf et al., 1998; 
Stevens & Williams, 2000). The latter mechanism has recently gained more evidence 
but still its predominance during exocytotic events is a matter of debate (Stevens & 
Williams, 2000; Aravanis et al., 2003a; Aravanis et al., 2003b; Lindau & Alvarez, 
2003). In fact some authors have demonstrated that in physiological conditions the 
kiss-and-run events are prevalent (~ 85 %) (Aravanis et al., 2003a; Aravanis et al., 
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2003b), while some others have observed a lower occurrence of this exocytotic 
mechanisms, although it can become more frequent under particular conditions. In 
fact an increase in the kiss-and-run mode from ~ 20% to over 80 % has been recorded 
during the superfusion of the synapses with a hypertonic solutions (Stevens & 
Williams, 2000) or in the presence of an elevated concentration of Ca2+ (Ales et al., 
1999). It has also been demonstrated that the “kiss and run” type of release is 
enhanced by the kinase inhibitor staurosporine, suggesting that this secretion mode is 
regulated by protein phosphorylation (Henkel et al., 2001). Furthermore, it is known 
that stability of the fusion pore kinetics is oppositely regulated by two different 
isoforms of synaptotagmin, a protein intimately associated with the fusion pore itself 
(Wang et al., 2001). In particular the overexpression of synaptotagmin I increased 
while synaptotagmin IV reduced the duration of the amperometric foot current 
indicating respectively an increased and a reduced lifetime of the fusion pore. 
 
2.3.2 Amount of neurotransmitter in the cleft 
Among the factors contributing to the presynaptic modulation of synaptic 
transmission such as the release mechanisms and the diffusion process, there is the 
variability of the amount of neurotransmitter present in the cleft. 
This parameter is strongly influenced by the volume and the number of vesicles 
released and by the concentration of neurotransmitter per vesicle. 
As clearly demonstrated for catecholamine-containing granules in chromaffin cells 
(Albillos et al., 1997) the neurotransmitter content is proportional to the volume of the 
vesicle. With amperometric measurements the catecholamine concentration inside the 
vesicles was calculated from the current recorded. The linear relation between the 
granule volume and the amperometric charge suggested that vesicles of different size 
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had a constant catecholamine concentration (Albillos et al., 1997). Thus the larger the 
volume of the vesicle, the more is neurotransmitter released in the cleft. The same 
indication was also found in cultured neurons of the leech (Bruns & Jahn, 1995; 
Bruns et al., 2000). It was estimated that in that preparation large vesicles were filled 
with 16-fold more serotonin than small ones. Therefore since the vesicle diameters 
vary, even if the molecular mechanisms for loading transmitter into the vesicles 
operated to achieve a fixed final concentration, the quantity of transmitter released 
would vary in proportion to the cube of the vesicle diameter (Bekkers et al., 1990). 
Although amperometric techniques have helped identifying of the correlation between 
the size and the content of catecholamine-containing vesicles, similar results have 
been found also for excitatory and inhibitory neurotransmitter (Bekkers et al., 1990; 
Frerking et al., 1995). Recently the linear relationship between quantal size and 
vesicle volume has been univocally determined in Drosophila glutamatergic 
neuromuscular synapses (Karunanithi et al., 2002). In fact naturally occurring and 
genetically-induced variations in vesicle size was correlated with quantal size 
fluctuations, thus reflecting variations in the vesicle content.  
Interestingly, the amount of neurotransmitter released per vesicle at individual 
boutons appears to change considerably (Liu et al., 1999). Variability of the vesicle 
transmitter concentration can arise by the modulation of vesicle loading. This process 
is influenced by several factors and leads to further heterogeneity in the amount of 
neurotransmitter released at each exocytocic event (Li & Chin, 2003). For instance the 
electrochemical gradient across the vesicle membrane is essential for adequate filling. 
Zhou et al., (2000) have demonstrated that the lack of the appropriate pH environment 
and electrical gradient due to the block of the vacuolar proton pump (V-ATPase) 
leads to a reduced activity of the neurotransmitter vesicular transporters. This in turn 
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implies that the vesicle transmitter content is decreased despite unaltered release 
mechanisms. The heterogeneity of the number, the type and the bioenergetics of 
vesicular transporters also brings further variability to the amount of neurotransmitter 
concentrated in the vesicles (McIntire et al., 1997; Reimer et al., 1998; Takamori et 
al., 2000; Bellocchio et al., 2000). In addition the efficacy of vesicle filling can also 
be influenced by modifications of the cytoplasmic neurotransmitter concentration. For 
instance the direct injection of glutamate in the presynaptic cytoplasm has been 
reported as an efficient tool to directly manipulate the transmitter cytoplasmic 
gradient (Ishikawa et al., 2002). This alteration produced a potentiation of evoked and 
spontaneous EPSCs, providing a clear proof that a larger cytoplasmic concentration of 
transmitter allows a more efficient loading of the vesicles. Several efforts have been 
made to estimate the concentration of transmitter present in the vesicles. In the rat 
neocortex different approaches of vesicle purification led to the estimation that each 
glutamatergic vesicle contained on average 3640 glutamate molecules to an 
equivalent intravesicular concentration up to ~ 0.21 M (Riveros et al., 1986; Burger et 
al., 1989). Similar estimations were found for serotonin concentration in cultured 
neurons of the leech. Extrapolations from amperometric measurements showed that 
small synaptic vesicles (SSV) and large dense-core vesicles (LDCV) contained 4700 
and approximately 80000 serotonin molecules, respectively at a concentration of ~ 
0.27 M (Bruns & Jahn, 1995; Bruns et al., 2000). An even higher vesicular transmitter 
concentration was estimated in chromaffin cells (0.7 M catecholamine) (Albillos et 
al., 1997). A still highly debated parameter influencing the amount of 
neurotransmitter released in the cleft is the number of vesicles released per synaptic 
bouton (Liu et al., 1999), which in turn depends on the number of active zones 
contained in each bouton and the number of vesicles released from each active zone . 
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Structural studies using freeze-fracture technique and electron microscopy (Tremblay 
et al., 1983; Forti et al., 1997; Schikorski & Stevens, 1997) combined with quantal 
analysis (Korn et al., 1993) have found that multiple active zones can be present 
opposite postsynaptic receptor matrices. Interestingly, it has been reported that the 
number of active zones is linearly related to bouton size (Hamos et al., 1987). Thus, 
in large boutons it is possible that neurotransmitter relesed from adjacent active zones 
can activate the same postsynaptic terminal.  Therefore the morphology of the 
synapse relevantly contributes to its functional properties, since the presence of one or 
many active zones can significantly modify synaptic strength. For many years the so-
called “one site - one vesicle” theory described the well-accepted notion that at 
maximum one vesicle per release site is released in a probabilistic manner with each 
action potential (Korn et al., 1994) despite the excess of vesicles apparently docked at 
the presynaptic membrane. This evidence was supported by the interesting 
coincidence of the number of the release sites histologically identified in Mauthner 
cells, and those estimated by fitting with a binomial release model the amplitude 
distribution of spontaneous currents recorded from the same cells (Korn et al., 1981). 
However mounting evidence supported the hypothesis (called “multivesicular 
release”) that, upon a stimulus, more than one vesicle could be released from a single 
active zone (Triller & Korn, 1982; Tong & Jahr, 1994; Auger et al., 1998). The 
existence of multivesicular release brings further variability to the concentration of 
the neurotransmitter in the cleft, by varying the number of the packets of transmitter 
released. However this hypothesis is heavily dependent on the assumption that 
postsynaptic receptors are far from saturation following the release of a single vesicle 
(Clements, 1996). Multivesicular release was first hypothesized at excitatory synapses 
of cultured hippocampal neurons (Tong & Jahr, 1994). Here, fast-off competitive 
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antagonists unraveled a larger glutamate cleft concentration in conditions of increased 
probability of release (Pr), e.g. elevated calcium levels, decreased presynaptic 
inhibition or paired-pulse facilitation. However these experiments did not provide 
clear evidence for multivesicular release, since the same results could also be 
explained in terms of spillover and pooling of glutamate molecules released at 
neighboring synapses (Auger & Marty, 2000). In fact recently Scimemi et al. (2004) 
have estimated that up to approximately 30% of NMDARs contributing to EPSCs are 
activated by glutamate released from neighboring synapses. If glutamate can readily 
diffuse from one synapse to the neighbors, higher cleft concentrations will occur 
when adjacent synapses release simultaneously than when only one does. Although 
this hypothesis is reasonable, Wadiche & Jahr (2001) have demonstrated that at least 
at climbing fiber-Purkinje cell (CF-PC) synapses multivesicular release is the only 
cause responsible for increasing glutamate concentration. The authors chose climbing 
fiber-Purkinje cell synapses since these synapses exhibit both physical and chemical 
barriers against spillover and therefore tend to be isolated. The analysis of non-
equilibrium inhibition of AMPA-mediated currents by fast-off antagonists in 
conditions of high and low Pr and reuptake blockade demonstrated that the peak 
concentration of glutamate correlates with Pr but it is not affected by spillover. 
Probably the clearest evidence for multivesicular release was found at GABAergic 
synapses (Auger et al., 1998). An accurate kinetic analysis of closely timed events 
observed in spontaneous synaptic currents and the study of the amplitude distribution 
of evoked IPSCs during high and low Pr, demonstrated that at least 30% of synaptic 
events are multiple. 
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2.3.3 Diffusion of neurotransmitter in the cleft 
The average movement of transmitter molecules within the cleft obeys diffusion 
dynamics. The propagation of the neurotransmitter concentration profile in the 
synaptic cleft over time can be described by a function C(x,y,z,t). This diffusion 
equation (also known as Fick’s second law) is defined as:   
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where C is the transmitter concentration, x, y and z are the three spatial variables, t the 
time and D the diffusion coefficient. In order to apply this equation to predict the 
dynamics of the transmitter concentration, the initial conditions (i.e., the concentration 
profile at t=0) and boundary conditions (i.e., the geometry of the cleft) have to be 
defined. Therefore also the kinetics of release and the efficiency of the uptake system 
should be adequately taken into account (see also paragraph 2.5 “Shaping synaptic 
currents”). 
The diffusion coefficient of neurotransmitters in the cleft is still unknown and only 
rough estimations of its value can be provided. The first quantification of a diffusion 
coefficient was that for glutamine in bulk aqueous solution i.e. 7.6 X 10-6 cm2/s 
(Longsworth, 1953). The same value is assumed to be valid also for glutamate in 
water, provided that the cleft environment is far from being an aqueous solution 
(Rusakov & Kullmann, 1998). It is widely accepted that the diffusion process within 
the synaptic cleft is slower than in a bulk solution because of the viscosity of the 
extracellular fluid, the interactions with the extracellular matrix and the basal 
membrane and limited space (Kleinle et al., 1996). Rice et al. (1985) estimated that 
the diffusion value should be reduced at least three times to be adapted for the 
synaptic cleft. Kleinle et al., (1996) have proposed a kinetic model for release and 
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diffusion of glutamate in the synaptic cleft in order to quantify the impact of the 
variability of the diffusion coefficient on the neurotransmitter transient in the cleft. 
The authors adopted the value previously used in modeling studies of diffusion in the 
cleft, i.e. 3 x 10-6 cm2 sec-1 (Wathey et al., 1979; Busch & Sakmann, 1990; Holmes, 
1995). The simulated profile of glutamate in the cleft reached its maximum (0.37 
mM) after 250 µs and declined to 10% after 2 ms. Lowering 10 times the value of the 
diffusion coefficient to 3 x 10-6 cm2 sec-1 led to a higher simulated peak concentration 
of glutamate (1.93 mM). Moreover both the time needed to reach the maximum of 
concentration and the concentration decay (clearance) were slower (290 µs and 2.7 
ms, respectively). Such dependence of the agonist profile on diffusion coefficient is 
reasonable since lower values of this parameter implicate slower and shorter lateral 
diffusion with consequent increase of peak concentration and slower rate of 
transmitter clearance. However it is interesting to note that also the instantaneous or 
continuous mechanism of release i.e. the rate of efflux of the transmitter from the 
vesicles is crucial for determining the transmitter peak concentration and time course 
seen by the post synaptic receptors (Kleinle et al., 1996). Since the transmitter invades 
the whole cleft within the first tens of microseconds after release, the concentration at 
pre and postsynaptic sites is comparable, even at lower values of diffusion coefficient. 
Therefore release mechanisms would influence the time needed to reach the peak of 
transmitter concentration and together with diffusion they would mainly regulate the 
early phase of transmitter clearance from the cleft. On the contrary the slower kinetics 
of the uptake process make it suitable to regulate transmitter clearance at a longer 
time scale (> 1 ms), when enough time has allowed the molecules to reach specific 
transporters (Clements, 1996).  
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Among the boundary conditions implied in the Fick’s equation there is the geometry 
of the synapse. So far the synaptic cleft has been usually approximated to a planar 
geometry. However a large heterogeneity is known to be present among different 
types of synapses. For instance in the hippocampus, mossy fibres (MFs) form large 
synaptic contacts at branched spiny structures in CA3 pyramidal cell dendrites. Three-
dimensional electron microscopy indicates that each MF bouton normally encloses a 
system of branched dendritic spines forming up to 50 synaptic active zones (Frotscher 
et al., 1988; Chicurel & Harris, 1992; Henze et al., 2002). This implies a large and 
tortuous synaptic cleft with the properties that cannot be easily represented by the 
planar geometry, thus making it difficult to assess the time course of intracleft 
glutamate released at this synapse (Savtchenko & Rusakov, 2004). Therefore the 
geometry of the environment in which diffusion occurs is important for regulating the 
exit of neurotransmitter molecules from the cleft (Barbour & Hausser, 1997). 
In conclusion, it is clear that the agonist time course critically shapes postsynaptic 
currents. Moreover it is worth noting that the speed of lateral diffusion together with 
the efficiency of uptake proteins, are also important for allowing transmitter spill-
over, thus tonic transmission. 
 
2.4 Postsynaptic modulation of synaptic transmission 
2.4.1 GABAA receptors: structure and subunit composition 
GABAA receptors are transmembrane proteins belonging to the ligand-gated ion 
channels superfamily. GABAA receptor channel is a heteroligomeric protein 
presumably composed of five subunits. Each subunit shows a large N-terminus, four 
hydrophobic transmembrane domains (M1–M4) connected by 2 intracellular loops 
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(between M1-M2 and M3-M4) and one extracellular loop (between M2-M3) and a 
short C-terminus exposed to the extracellular space.  
 
Bormann J. Trends Pharmacol Sci. 2000 Jan;21(1):16-9. 
 
The large extracellular N-terminus contains the binding site, a cysteine bridge and 
glycosylation sites. The M2 transmembrane domain of each of the five subunits lines 
the pore, thus determining anion permeability (Xu et al., 1995; Smith & Olsen, 1995). 
The intracellular loop between M3 and M4 contains phosphorylation sites for protein 
kinase A (PKA), protein kinase C (PKC), and tyrosine kinase. So far, nineteen subunit 
sub-types have been cloned. These subunits are divided, according to their degree of 
homology in seven sub-families (α1−6, β1−3,  γ1−3, δ, ε, θ, π, ρ1−3) (Luddens & Wisden, 
1991; Macdonald & Olsen, 1994; Whiting et al., 2001). Further diversity among 
subunits can originate from alternative splicing. For instance, γ2S and γ2L are two 
different splicing forms of γ2 subunit (Whiting et al., 1990). In theory thousands of 
different combinations could result form the assembly of all receptor subunits and 
their splice variants. However GABAA receptors do form preferred assemblies, 
leading to only dozens of distinct subunit combinations actually present in the brain 
(Sieghart & Sperk, 2002; Whiting, 2003). Although the most common arrangement 
found in the brain is two α, two β and one γ/δ/ε subunits (Sieghart, 1995), a large 
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heterogeneity of GABAA receptors with different stoichiometry and subunit 
combination could be present.  
Several studies in recombinant systems, together with KO mice and pharmacology 
have contributed to identify the characteristics imparted by individual subunits to the 
whole receptor (Fisher & Macdonald, 1997; Bianchi et al., 2002; Goldstein et al., 
2002). For instance it was possible to assess that the substitution of the δ subunit with 
the γ2, conferred lower apparent affinity to the receptors and endowed the 
corresponding currents with faster onset, slower decay and larger extent of 
desensitization (Fisher & Macdonald, 1997; Haas & Macdonald, 1999). KO mice 
lacking the α1 subunit were extremely useful to identify the contribution of that 
subunit to mIPSCs decay and amplitude and to clearly localize them in the 
hippocampal slices (Goldstein et al., 2002). In fact mIPSCs recorded from α1 KO 
mice were detected less frequently, were smaller in amplitude and decayed more 
slowly than mIPSCs recorded in neurons from WT mice. Moreover these differences 
could be observed only in interneurons and pyramidal cells, thus suggesting the 
localization of α1 subunit. 
A further source in the variability of GABAA receptor subunit composition is the 
differential expression of specific subunits during development (Thompson & 
Stephenson, 1994; Lavoie et al., 1997). For instance it has been proposed that changes 
in decay kinetics of GABAergic mIPSCs observed in the hippocampus during 
development can be attributed to the replacement of α2 subunit by α1. In fact in 
neonates the presence of α2 is associated with GABAergic mIPSCs exhibiting slow 
decay, while in adults faster decay is related to the presence of α1 subunit (Hollrigel & 
Soltesz, 1997; Lavoie et al., 1997). Recently a similar correlation between the 
accelerated kinetics of mIPSCs and the shifted expression of the alpha subunit from 
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α2 and α3 to α1 has been observed during maturation of primary cultures of cerebellar 
granule cells (Ortinski et al., 2004). 
 
2.4.2 GABAA receptors: localization 
Diverse GABAA receptors subtypes are known to be differently expressed not only 
over time (during development), but also in space (in different brain regions and in 
different subcellular areas, e.g. synaptic and extrasynaptic).  
Immunocytochemistry, immunogold and immunoprecipitation techniques have been 
used to establish the differential distribution of native GABAA receptor subtypes in 
different regions of the brain and at subcellular level (Thompson & Stephenson, 1994; 
Nusser et al., 1995; Khan et al., 1996; Nusser et al., 1998; Kannenberg et al., 1999; 
Christie et al., 2002a). While some subunits such as the α, β and γ exhibit 
heterogeneous distribution across different anatomical areas, others are more 
confined. For instance the ρ subunit is predominantly expressed in the retina and the ε 
subunit is in the subthalamic nucleus (Davies et al., 1997). Detailed studies have 
demonstrated that α6-containing receptors are exclusively expressed in the cerebellar 
granule cells and that they preferentially coassemble with α1, β2/3, γ2, and δ (Luddens 
et al., 1990; Gao & Fritschy, 1995; Rossi & Hamann, 1998). In the hippocampus α1 
and β2 subunits show an almost uniform distribution, while α2 and β3 subunits 
preferentially accumulate in the dentate gyrus and in the CA3 area and α5 and β1 
subunits are highly expressed in the CA1 and in the dentate gyrus (Laurie et al., 1992; 
Christie et al., 2002a). On the contrary low levels of α4, δ, γ1 and γ3 subunits are 
found in the hippocampus (Christie et al., 2002a).  
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The immunogold technique has been widely used for identifying receptors subtypes 
targeted to functionally different parts of a neuron. In hippocampal pyramidal cells α2 
subunits are present only in a subset of synapses at the axon initial segment, whereas 
α1 are uniformly distributed in synapses over the axo-somato-dendritic domains 
(Nusser et al., 1996; Essrich et al., 1998). The immunolabeling of the γ2 subunit has 
shown that it is present in hippocampal basket cell synapses on the somata and 
proximal dendrites and in axo-axonic cell synapses on the axon initial segment of 
pyramidal and granule cells (Nusser et al., 1996). 
 The different localization of GABAA receptor subtypes can be further classified 
among synaptic and extrasynaptic sites. In fact both immunolabeling and immunogold 
approaches have allowed elucidating the presence of some GABAA receptor subunits 
also at extrasynaptic locations (Nusser et al., 1995; Nusser et al., 1998; Christie et al., 
2002b; Danglot et al., 2003). The most compelling evidence for extrasynaptic 
subtypes comes from the localization of the δ subunit in the hippocampus and in the 
cerebellum (Fritschy & Mohler, 1995; Saxena & Macdonald, 1996; Sperk et al., 1997; 
Nusser et al., 1998; Wei et al., 2003). While the δ subunit is exclusively expressed at 
extrasynaptic sites, other subunits can be found both at synaptic and at extrasynaptic 
locations. For instance, different approaches have decorated γ2 subunits both inside 
and outside synapses in cultured hippocampal neurons (Nusser et al., 1998; Danglot et 
al., 2003). It is almost widely accepted that extrasynaptic receptors are those 
mediating tonic inhibition (Kaneda et al., 1995; Brickley et al., 1996; Nusser et al., 
1998; Rossi & Hamann, 1998). Therefore the assembly of specific subunits at 
extrasynpatic sites can endow tonic currents with peculiar characteristics. It has been 
also demonstrated that extrasynaptic receptors exhibit lower conductance levels 
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compared to synaptic ones, thus probably making them more suitable to mediate a 
persistent inhibitory conductance (De Koninck & Mody, 1994; Brickley et al., 1999). 
 
2.4.3 GABAA receptors: pharmacology 
The activity of GABAA receptors can be influenced by a number of endogenous and 
exogenous modulators, often in a subunit dependent manner (Moss & Smart, 1996; 
Hevers & Luddens, 1998). Among endogenous factors, protein kinases have been 
reported to play an important role in regulating the action of GABAA receptors. It has 
been demonstrated that protein kinase A (PKA) and protein kinase C (PKC) are able 
to reduce and enhance respectively GABAA receptors mediated currents in a subunit 
and cell-dependent way (Poisbeau et al., 1999). For instance, PKA but not PKC, 
reduces mIPCSs amplitude in pyramidal cells, whereas in granule cells PKC but not 
PKA enhances the peak amplitude of mIPSCs (Poisbeau et al., 1999). Moreover, 
PKA-mediated phosphorylation strongly depends on the β subunit (McDonald et al., 
1998). PKA enhances mIPCSs amplitude in olfactory granule cells that express only 
β3 as the β variant (Nusser et al., 1999), but reduces it in hippocampal CA1 pyramidal 
cells that express β1 subunit (Poisbeau et al., 1999). Since it has been demonstrated 
that effects of phosphorylation on synaptic currents are detectable in the time scale of 
minutes, it is conceivable that this process (as well as dephosphorylation) can 
contribute to long-term changes of synaptic efficacy (Roche et al., 1994; Swope et al., 
1999). In addition, protons and neurosteroids are also potent endogenous GABAA 
receptor modulators (Krishek et al., 1996; Zhu & Vicini, 1997; Mozrzymas et al., 
2003a). The physiological relevance of the modulation of GABAA receptor by protons 
is due to the fact that activation of GABAA receptors leads to a net efflux of HCO3- 
that can transiently change the extracellular pH (Kaila, 1994). In an accurate kinetic 
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study protons proved to significantly alter the gating of GABAA receptors by 
increasing their desensitization and affinity (Mozrzymas et al., 2003a). The 
modulation of GABAA receptors by protons is strongly dependent on the subunit-
composition. While protons increase the α1β1 and α1β1δ-mediated currents, they are 
ineffective on α1β1γ2Sδ currents. Moreover, protons decrease currents mediated by 
α1β1γ2S receptors (Krishek et al., 1996).  
Neurosteroids have been demonstrated to potentiate GABAA-mediated currents by 
prolonging their deactivation process (Zhu & Vicini, 1997). Also neurosteroids 
exhibit a subunit-dependent efficacy. In particular, the presence of α6 and δ subunits 
has been shown to increase and decrease the sensitivity of GABAA receptor to 
neurosteroids, respectively (Lambert et al., 1999).  
GABAA receptors can be allosterically modulated by a number of exogenous 
molecules including benzodiazepines, barbiturates, anesthetics, ethanol and Zn2+.  
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Benzodiazepines (BDZ) and barbiturates are widely used for the treatment of 
neuropsychiatric disorders such as anxiety, epilepsy etc. It is widely accepted that 
benzodiazepines enhance GABAergic transmission by increasing the probability of 
channel opening (Macdonald et al., 1989; Vicini et al., 1987). Benzodiazepines have 
also been shown to increase GABAA receptor single channel conductance, although 
this effect is still under debate (Eghbali et al., 1997; Rang et al., 2003). 
Benzodiazepine sensitivity is highly dependent on GABAA receptor subunit 
composition. Essential requirement is the presence of the γ subunit (Pritchett et al., 
1989; Luddens et al., 1995; Wingrove et al., 1997), since the BDZ-specific binding 
site lies between γ and α subunits. Moreover several studies have demonstrated that 
the different subunits can modulate benzodiazepine sensitivity of the whole receptors. 
For instance α4, α6 and ρ subunits appear to confer insensitivity to these drugs 
(Mohler & et al., 2000). 
Barbiturates are known to enhance the effects of GABAA receptor agonists by 
increasing the mean open time of the channels i.e., to enhance the probability and 
duration of channel opening without altering receptor conductance or opening 
frequency (Study & Barker, 1981; Macdonald & Twyman R.E., 1992; Macdonald & 
Olsen, 1994; Steinbach & Akk, 2001).  At high concentrations (>50 µM) which are 
reached in plasma during anesthesia with pentobarbital (Franks & Lieb, 1994) 
barbiturates are able to directly open the channels in the absence of GABA (Inomata 
et al., 1988). Several anestetics, anxyolitic drugs, sedative hypnotic and 
anticonvulsant commonly used in clinics belong to the family of steroids and interact 
with GABAA receptors (Sieghart, 1995). At low concentrations (30 to 300 nM) they 
enhance GABA-mediated chloride conductance (Majewska, 1992). At higher 
concentrations (> 1 µM), which occur during surgical anesthesia, these compounds 
 26
produce a direct opening of GABAA receptors (Callachan et al., 1987).  Although 
barbiturates and neurosteroids exert similar effects on GABAA receptors, they clearly 
act through different sites (McKernan & Whiting, 1996).  
Another GABAA receptor enhancing compound is ethanol (Davies, 2003). A number 
of experiments have assessed that ethanol increases GABA-mediated current thus 
leading to a greater hyperpolarization of the postsynaptic membrane and a further 
decrease in neuronal excitability (Suzdak & Paul, 1987; Siggins et al., 1987; Frye et 
al., 1994). So far, it appears that ethanol effect on GABAA receptors is subunit 
independent (Mihic et al., 1994). However the α4β1δ subtype seems to be more 
sensitive to ethanol than other receptor subtypes tested (Sundstrom-Poromaa et al., 
2002).  
Among the substances that inhibit GABAA receptors, zinc is probably the most 
studied (Westbrook & Mayer, 1987; Smart et al., 1994). Several mechanisms have 
been put forward to account for the zinc-induced reduction of GABA-mediated 
currents. It has been proposed that zinc affects GABA-induced currents by reducing 
the frequency of channel openings (Legendre & Westbrook, 1991), an effect that 
could be achieved either by decreasing or increasing GABA binding or unbinding rate 
constants, respectively. However, these possibilities have been considered unlikely 
due to the lack of zinc effects on GABAAR single-channel kinetics (Legendre & 
Westbrook, 1991; Smart, 1992; Smart et al., 1994). The possibility that binding of 
Zn2+ might allosterically trigger a transition to a long-lived non conducting state has 
been suggested (Celentano et al., 1991; Smart, 1992; Smart et al., 1994; Gingrich & 
Burkat, 1998) but the mechanism of such modulatory effect has not been fully 
clarified. Alternatively, Zn2+ could increase the onset of desensitization, a 
phenomenon that may be responsible for the acceleration of GABA-induced current 
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deactivation (Berger et al., 1998). Modulation of GABAA receptors by endogenous 
Zn2+ has profound implications for developmental and pathological processes, in 
particular, epilepsy. Experimental status epilepticus has been associated with a 
decreased Zn2+ sensitivity of GABAA receptors (Banerjee et al., 1999; Kapur & 
Macdonald, 1997). Recently Zn2+ modulation on GABAA receptors has been 
described also in physiological conditions. Ruiz et al., (2004) have reported that 
endogenously released Zn2+ reduces the amplitude of GABA-mediated IPSCs in the 
CA3 area, although this effect is significantly smaller than in pathological conditions. 
It has been assessed in our laboratory that the block of mIPSCs by zinc is not due to a 
direct block of the channel pore but rather to an allosteric modulation of GABAA 
receptors, i.e. alteration of their affinity, efficacy and desensitization (Barberis et al., 
2000). The action of Zn++ on GABAA receptor is dependent on subunit composition. 
In fact the presence of the γ subunit drastically reduces the sensitivity of GABAA 
receptors for zinc ions (Saxena & Macdonald, 1994). Furthermore the different α 
subunits also seem to play an important role in the sensitivity of GABAA receptors to 
zinc ions (Saxena & Macdonald, 1994). Recently we demonstrated in a recombinant 
system that the absence of the γ2 subunit from GABAA receptors, allows also a direct 
block of the channel pore by zinc (Barberis et al., 2002). 
 
2.4.4 GABAA receptor gating  
Del Castillo & Katz (1957) have defined the basic gating scheme for ligand-gated ion 
channel as:  
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(3) 
where R is the receptor in the unbound state, A is the ligand molecule, AR is the 
receptor bound closed, AR* is the receptor bound open. The rate constants governing 
these processes are kon, koff, β and α. This gating scheme shows that the receptor in the 
unbound state reaches the open state in two steps: the binding of the agonist molecule 
and the transition from bound-closed to bound-open states. This can be considered a 
basic characteristic shared by all ligand-gated receptor channels. Thus, binding of the 
agonist molecule(s) facilitates the conformational transition to the open state. 
However, the gating of GABAA receptor (as any other fast-ligand gated receptor) 
appears to be more complex than that proposed in scheme (3). In fact, in order to 
describe at least the basic properties of the GABAA-mediated current, desensitization 
has to be taken into account. The most general definition of desensitized state is a 
non-conductive state of the receptor that is kinetically distinct from the unbound state 
and bound-closed state. Usually, the rate of exit from desensitized states 
(resensitization rate, r) is rather slow implying that the receptors remain trapped in 
this state for relatively long periods. Thus, the observed fading of the macroscopic 
current in the presence of agonist is due to the progressive trapping of the receptors in 
the desensitized state. It is not clear if the receptor can enter the desensitized state 
from the bound, unbound, open or closed states. Despite intense study, the 
conformational modifications (induced by the agonist binding) underlying the 
transition of the receptor in the different states are not precisely defined yet. Recently, 
it has been proposed that the open state can be achieved by a rotation of the M2 
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segments induced by agonist binding (Horenstein et al., 2001). This conformational 
change probably promotes the removal of the closed channel gates from the pore 
leaving it free for ions permeation.  
Gating of GABAA receptors shows peculiar properties. Unlike other ligand-gated 
receptors such as ACh receptor, binding of the agonist molecule to the receptor is not 
a diffusion-limited process (Colquhoun & Sakmann, 1985). In that case the affinity of 
the agonist for its receptor (koff/kon) would be mainly due to the unbinding rate 
constant (koff) since the binding rate is thought to be faster than diffusion and therefore 
it should not be the rate-limiting step of the binding process. On the contrary Jones et 
al., (1998) have demonstrated that the binding rate of GABA for GABAA receptor is 
orders of magnitude slower than that expected for free diffusion. This fact implies that 
the binding of the GABA molecule to GABAA receptor requires a significant amount 
of energy. The same authors, using agonists with different length, have also shown 
that the binding rate constant (kon) is inversely correlated with the unbinding rate 
constant (koff). This behavior can be explained if short agonists (such as β-alanine) 
require large activation energy (slow binding rate) and only slightly stabilize the 
agonist-receptor complex (fast unbinding rate). On the contrary longer agonists (such 
as GABA) exhibit a smaller activation barrier energy (relatively fast binding rate) and 
significant stabilization (slow unbinding rate). These data allowed Jones et al., (1998) 
to propose a “flexible binding site” as a representative model for the binding site of 
GABAA receptors. In fact the binding event would consist of the stretching of two 
flexible “arms” that bind the agonist molecule. Therefore the longer the agonist, the 
smaller would be the barrier of activation energy. After the binding, the stretched 
conformation of the site determines the stability of the complex. Jones et al. (1998) 
have demonstrated that longer agonists exhibit higher stabilization after the binding. 
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This scenario shows that the affinity of GABA for GABAA receptors is strongly 
affected by the binding process and that the ligand-specific energy barrier for binding 
determines the agonist selectivity of GABAA receptors. It is interesting to point out 
that, as demonstrated by Jones et al. (2001) GABAA receptor competitive antagonists 
differ from agonists since they do not show the correlation between binding, 
unbinding and affinity. In particular, antagonists exhibit faster binding rates and lower 
activation energies than the agonists. Thus the energy required for the binding process 
is somehow related to the ability of the ligand to drive the channel gating. This is 
consistent with the hypothesis that the agonist binding promotes movements within 
the binding site that lead to channel gating (Williams & Akabas, 1999; Jones et al., 
2001), while antagonists binding do not.   
In addition, the gating of GABAA receptor shows other peculiarities. It is known that, 
after a pulse of agonist, current deactivation is much slower than that predicted by the 
unbinding rate constant. This is basically due to the fact that deactivation, 
desensitization and opening processes are functionally coupled since they have 
comparable rate constants (Mozrzymas et al., 2003b). Hence, immediately after the 
agonist pulse is over the unbinding is not the only process that takes place, but also 
multiple entrances in the desensitized state and reopening can be observed before the 
unbinding. This implies that the deactivation process is strongly prolonged. Taken 
together all these data confirm that gating of GABAA receptor is a very complex 
process.  
However, in spite of this high level of complexity, the transitions between different 
conformational states of GABAA receptor fulfill the criterion of Markovian processes 
following the mass action law. Taking advantage of this property it would be possible 
to provide a representative simplification of GABAA receptor gating. In fact, once the 
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number of conformational states and the value of the rate constants governing the 
transitions between different states have been defined, it would be possible to 
simulate the gating of the receptor. Applying the mass action law, every transition can 
be described by a differential equation and the gating scheme can be converted into a 
set of differential equations. By solving this differential equation system it is possible 
to know the time course of the occupancies of all the states. The occupancy of the 
different states is given in terms of probability and it concerns the average behavior of 
the system. Given the large number of equations involved, an integrated solution 
would be difficult to obtain; therefore this systems are usually solved numerically.  
Several models have been proposed to describe the gating of ligand-gated ion 
channels. As already mentioned, Del Castillo & Katz (1957) first suggested that the 
activation of ligand gated channels occur in at least two steps: the binding of the 
agonist to the receptor and consequent conformational change of the ‘agonist-
receptor’ complex that finally determines the opening of the channel (see eq. 3).  
Based on the work of Colquhoun & Hawkes (1981), Bormann & Kettenmann (1988) 
have proposed a gating scheme for GABAA receptor that included the sequential 
binding of two molecules of GABA to the receptor (as suggested from the Hill 
coefficient ~ 2). This scheme also includes the possibility of opening from a singly 
bound state:  
R AR A
2
R
2kon
koff
AR* A2R*
2koff
kon
α1 β1 α2 β2
 
(4) 
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where R is the unbound receptor, AR the singly bound-closed receptor, AR* the 
singly bound-open while A2R and A2R* respectively the double bound closed and 
open state. 
Analyzing the single channel properties of GABAA receptors, Macdonald et al. (1989) 
have suggested a different kinetic scheme in which three kinetically distinct open 
states are present and cyclically connected. In 1995 Gingrich et al. have proposed a 
kinetic model that includes desensitization. By the time passing many more kinetic 
schemes have been hypothesized, all exhibiting increasing complexity.  
The kinetic model that probably represents the best compromise between low level of 
complexity and satisfactory capability of describing GABAA-mediated macroscopic 
currents is the one proposed by Jones & Westbrook (1995).  
It contains a small number of conformational states thus reducing its degeneration, but 
still allowing a good representation of GABAA receptor gating. This simplified 
scheme is defined as:  
A2R
2kon
α2β2α1 β1
AR
r2
AD
d2
AR* A2R*
AD2
R
kon
2koff2koff
r1 d1
(5) 
where R is the unbound receptor. One or two molecules of agonist(s) (A) can bind to 
the receptor. From singly- and doubly- bound closed states (AR and A2R, 
respectively) originate both open and desensitized states (AR*, AD, A2R*, A2D). 
Since at saturating GABA concentrations the singly-bound states are poorly occupied, 
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according to this scheme the onset of desensitization induced by a prolonged 
application of saturating GABA concentration will be mono-exponential (only one 
desensitized state originates from the doubly-bound state). This behavior is different 
from that experimentally observed. In fact the onset of desensitization induced by a 
prolonged application of saturating GABA can be fitted by several exponential 
components, indicating that more than one desensitized states is present. In particular, 
a very fast component (τ = 3-10 msec) and slower components have been described 
(Celentano & Wong, 1994; Overstreet & Westbrook, 2001). However, it has to be 
emphasized that, very likely, currents evoked by a brief pulse of agonist (≤ 2ms) are 
poorly affected by the slow desensitization components. Thus this model seems to be 
adequate to describe the GABAA currents evoked by brief pulses of agonist at high 
concentration, as occurs for instance in the synaptic cleft after synaptic release. 
Nevertheless this model appears appropriate also for studying the behavior of GABAA 
receptor at low dose of agonist. In particular, the presence of a desensitized state 
originating from the singly bound closed state is very important to explain the gating 
of GABAA receptor at tonic and low agonist concentrations.  
However it must be pointed out that this model was first developed to provide a 
general gating scheme able to account for GABAergic synaptic currents. In particular, 
the authors have referred to GABA-evoked and synaptic currents recorded from 
cultured hippocampal neurons, which were inherently elicited by a heterogeneous 
population of GABAA receptor subtypes. Therefore, when referring to this model it 
must be taken into account that it does not aim at describing the gating properties of a 
specific GABAA receptor subtype, rather the “average” behavior of GABAA receptors 
in the hippocampus. 
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2.5 Shaping synaptic currents 
As already mentioned synaptic current results from a series of events occurring in 
rapid succession including transmitter release, transmitter diffusion, transmitter 
binding to the receptor and post-synaptic receptors gating. In the previous paragraphs 
most of the factors involved in generating and regulating phasic transmission have 
been described, both at presynaptic/cleft and postsynaptic level. While discussing 
each of these events, it has already pointed out that their variability can generate 
different synaptic responses. However the influence of the kinetics and the variability 
of the processes described above in influencing the concentration profile of the 
transmitter in the cleft (transient) and the gating properties of the post-synaptic 
receptors cannot be analyzed separately. Therefore in this section an implemented and 
integrated view of the shaping of postsynaptic currents will be presented.  
The shape of the post-synaptic currents is crucial for both the spatial and the temporal 
summation of excitatory and inhibitory inputs determining thus the capacity of the 
membrane to fire action potentials. This implies that, by interfering with the time 
course of post-synaptic currents it is possible to substantially change synaptic output, 
with potentially very important consequences for the network coding.  
 
2.5.1 Postsynaptic receptor saturation 
The synaptic agonist transient is thought to be extremely fast (1-5 mM with clearance 
time constant of ∼ 100 µs) (Clements, 1996). Such a brief transmitter transient is even 
faster than GABAA receptor opening, implying that synaptic receptor activation 
occurs in conditions of non-equilibrium. However, it is not clear whether this 
transmitter pulse (assumed to be due to the release of a single transmitter vesicle) is 
able to saturate post-synaptic receptors (i.e., to maximally activate the receptors so 
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that larger concentrations of agonist would produce the same response) (Frerking & 
Wilson, 1996). Receptor saturation is a particularly interesting issue, since it suggests 
if the variability of synaptic currents originates at pre- and/or post-synaptic level. This 
in turn becomes physiologically relevant for identifying pre- and/or post-synaptic 
substrates for the short- and long-term changes in synaptic strength.  
If the repetitive release of synaptic vesicles (during synaptic transmission) does not 
saturate receptors, the heterogeneity of postsynaptic currents would depend on both 
pre- and post-synaptic sources of variability. On the other hand if receptors were 
saturated, synaptic currents would not reflect any change of the transmitter 
concentration and time course in the cleft. They would rather be influenced by 
postsynaptic parameters such as the stochastic nature of receptor gating (Faber et al., 
1992). In fact, since receptor gating is known to be a Markovian process, stochastic 
variation of single channel currents upon the same stimulus would turn out in 
macroscopic currents as well. Therefore receptor openings can be only expressed in 
term of probability. The more Po approaches Pomax, the more would saturation be 
approached and current variability reduced. It is worth mentioning that during 
repetitive release of synaptic vesicles also receptor desensitization could significantly 
contribute to the variability of synaptic currents, in particular if the instantaneous 
frequency of release is comparable to (or higher than) the rate constant describing the 
entry and the exit from the desensitized state (Rigo et al., 2003). Therefore, for a 
given kinetics of desensitization, the higher the frequency of release, the lower would 
be the probability that receptors exit from desensitized states in the time gap between 
two consecutive release events and the smaller would be the response to the 
subsequent release. In order to address the issue of receptor saturation, the degree of 
occupancy of post-synaptic receptors following release of a single transmitter vesicle 
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has been analyzed with several approaches. With the “occlusion method” (Tang et al., 
1994; Auger & Marty, 1997) studied consecutive mIPSC separated by a time interval 
δ t  during high frequency burst evoked by α-latrotoxin in order to estimate receptor 
occupancy. After the peak, the occupancy (ω) of a first synaptic event due to 
unbinding of transmitter from the receptors, relaxes back to zero and will be ω(δ t ) at 
the time δ t . Thus, if a second event occurs at the time δ t , the fraction of available 
receptors at that time will be 1 - ω(δ t ). Being I1 the amplitude of the first synaptic 
event and I2 the amplitude increment of the second event, the fraction of available 
receptors can also be expressed as I2/I1, so that: 
)(1
1
2 t
I
I δω−=  (6) 
Plotting I2/I1 as a function of δ t , it is possible to extrapolate the value I2/I1 at the time 
δ t  = 0 and calculate the value of the peak occupancy ω 0 . The value (Auger & Marty, 
1997) found was 0.76. They suggested that GABAA receptors were not saturated. 
However, desensitization and contamination by GABA coming from neighboring 
release sites may lead to possible errors while using this method. At inhibitory 
synapses the degree of occupancy of the post-synaptic receptors following the release 
of a transmitter quantum has been also studied taking advantage of the 
pharmacological effect of benzodiazepines (BDZ). These drugs are believed to 
increase the affinity of GABA for GABAA receptor. Thus, if the post-synaptic 
receptor cluster is not saturated, application of BZD is expected to increase the 
mIPSC amplitude. On the other hand if saturation occurs, BZD are expected to fail to 
increase the mIPSC amplitude. Using this method, conflicting results have been 
reported. De Koninck & Mody (1994) and Poncer et al. (1996) studying mIPSCs in 
hippocampus (CA3 pyramidal cells) found that BDZ do not increase the peak 
 37
amplitude of mIPSCs indicating that in these synapses GABAA receptors are 
saturated. According to the increase in the GABA affinity for its receptor, the decay 
time of miniature currents was slowed down. In contrast, in other preparations 
including cerebellar stellate cells (Nusser et al., 1997), cultured cerebellar granule 
cells (Mellor & Randall, 1997), cortical slices (Perrais & Ropert, 1999) and cultured 
retinal amacrine cells (Frerking et al., 1995) BDZ increased the mIPSCs peak 
amplitude. Moreover the effect of BDZ has been reported to be temperature 
dependent. In fact Perrais & Ropert (1999) found that zolpidem enhanced mIPSCs 
only at room temperature and not at physiological temperatures. It has to be pointed 
out that the effect of BDZ has not been fully elucidated yet and their action depends 
on the subunit composition of GABAA receptors. Thus the observed variability could 
be due to the different GABAA receptors subunit composition at different 
preparations.  
Another method to assess receptor saturation is to estimate the degree of occupancy of 
post-synaptic receptors by studying the coefficient of variation (CV) of the amplitude 
of miniature post-synaptic currents. This method is conceptually based on the fact that 
a full occupancy of the post-synaptic receptors (saturation) determines a very low 
coefficient of variation while a partial occupancy presupposes higher coefficient of 
variation values. Thus, measuring the coefficient of variation at a single release site it 
is possible to estimate the value of occupancy of the post-synaptic receptor cluster. 
More precisely, the value of the coefficient value is defined as: 
     
0
01
N
PCV −=  (7) 
where P0 is the peak opening probability (defined as the product of the peak 
occupancy ω0 and the probability that bound channels are open p0), N0 is the product 
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between P0  and the total number of channels in the receptor cluster. At central 
synapses N0 is in the range of 10-100. For small and medium values of P0 (≤ 0.5), 
application of eq. (7) predicts CV values of 7 – 32 %. CV values below 7 % indicate 
P0 values above 0.5 and even higher occupancy values (Auger & Marty, 2000). 
Assuming the values of open probability and number of channels (per receptor 
cluster) estimated in previous works, the full occupancy of the post-synaptic receptors 
after quantal transmitter release would provide a much smaller coefficient of variation 
value than that experimentally observed at a single release site. However this method 
has been predominantly applied to excitatory synapses to demonstrate the incomplete 
occupancy of postsynaptic receptor clusters (CV = 28 % and 50%, from Liu & Tsien, 
1995 and Forti et al., 1997, respectively). 
Nowadays the hypothesis that post-synaptic receptors are not saturated by the release 
of a single transmitter vesicle is progressively more supported (Liu, 2003). 
Nevertheless, it is difficult to assess whether this assumption can be generalized to all 
synapses. It is in fact possible that in given conditions (receptor affinity, synapse 
geometry etc.), post-synaptic receptors work in condition of saturation (Frerking & 
Wilson, 1996). This is probably the reason why several fully contradictory papers 
exist on this topic (Poncer et al., 1996; Perrais & Ropert, 1999). 
 
2.5.2 Factors contributing to the variability of the agonist transient in the cleft 
Assuming the non-saturation of postsynaptic receptors, it is reasonable to expect that 
slight changes in the transmitter peak and time course in the cleft may result in large 
variability of postsynaptic current properties. The peak and time course of transmitter 
concentration depend on several parameters (most of which have been already 
described in previous paragraphs) including 1) the concentration of transmitter in the 
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vesicle, 2) the rate of transmitter efflux through the synaptic vesicle fusion pore, 3) 
the number of vesicles simultaneously released in the cleft, 4) synchronous or 
asynchronous modality of transmitter release, 5) the transmitter diffusion coefficient, 
6) the geometry of the cleft and the adjacent extrasynaptic space, 7) the distribution 
and the affinity of transmitter binding sites (channels and transporters) and 8) GABA 
transporters.  
Although most of these factors have been discussed before, it is worth mentioning 
other possible parameters that can further contribute to the variability of synaptic 
currents. For instance it has been reported that quantal release can switch form a 
highly synchronized, action-potential dependent mode, to an asynchronous one upon 
persistent high frequency stimulation (Lu & Trussell, 2000) or application of Sr2+ 
(Oliet et al., 1996). This phenomenon has been ascribed to a raise in the intraterminal 
Ca2+ concentration, facilitation of vesicle release and short-term depletion of available 
vesicles (Lu & Trussell, 2000; Kirischuk & Grantyn, 2003) 
A further source of variability is the possibility that mIPSCs originate from single or 
different release sites from the same synaptic bouton. In the latter case different 
characteristics among the release sites including their variable electronic distance 
from the recording electrode may contribute to further variability. In fact currents are 
usually recorded from the soma, therefore raising the possibility that cable attenuation 
may occur. The comparison between the variance of synaptic currents coming from a 
single release site and that of events coming from all the release sites is a good tool to 
detect the presence of additional variability due to multiple-site release. As reviewed 
by Auger & Marty (2000) different approaches have been used to record miniature 
synaptic currents coming from a single release site. These methods have lead to 
contradictory results and interpretations. For instance Liu & Tsien (1995) triggered 
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release at putative single release sites (localized with the fluorescent indicator FM1-
43) by focally applying a high potassium containing solution in the presence of TTX. 
The single site variance of the post-synaptic currents was very large (40-50%) and 
comparable with the variance obtained considering post-synaptic currents coming 
from all the release sites (40-50%). These experiments suggest that variability 
depends on the properties of the single release site. In contrast, Forti et al. (1997) 
proposed that the main source of variability could be due to the difference among 
release sites and/or electrical distance from the recording electrode. In fact they found 
that the coefficient of variation at the single release site was smaller than that 
observed considering the population of all the release sites (28% and 72%, 
respectively). However, it must be pointed out that different approaches to record 
from single sites might lead to bias. In fact, similarly to Auger & Marty (1997), Forti 
et al. (1997) localized single sites with FM1-43, but then they recorded from single 
synaptic boutons contained in the recording pipette (“loose patch clamp”) in the 
presence of TTX. Taken together these results indicate that also at single release sites 
some variability in the amplitude of miniature synaptic current is present.  
It is also worth noting that the stochastic nature of synaptic receptor activity can 
represent a source of synaptic variability. This possibility becomes more evident when 
the number of channels available at the synapse is small, thus the inherent fluctuations 
in channel behavior can significantly increase the variability of the macroscopic 
postsynaptic currents. With Monte Carlo simulations and the analysis of inhibitory 
quanta in embryonic and adult Mauthner cells (involving a small and large number of 
channels, respectively) Faber et al. (1992) demonstrated that the stochastic behavior 
of the receptors produces significant intrinsic variance in the current amplitude and 
kinetics, particularly when few receptors are present at a synapse. Monte Carlo 
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simulations have been used to reproduce the whole process of fast excitatory 
transmission at glutamatergic synapses by simulating three-dimensional random walk 
diffusion of transmitter molecules and bimolecular reaction kinetics in complex 
spatial environments reflecting realistic cellular ultrastructures (Franks et al., 2002). 
This approach allowed investigating and comparing the effect of the variability of 
single steps of synaptic transmission on the overall result (e.g., synaptic currents). For 
instance, Franks et al. (2002) demonstrated that peak amplitude responses are more 
sensitive to increases in the number of receptors than in the amount of transmitter 
released, since in the latter case receptors progressively approach saturation. A more 
accurate investigation of the influence of morphological parameters on synaptic 
variability has been recently provided (Franks et al., 2003). The authors have studied 
the contribution of the cleft size and the PSD density and shape on the variability of 
simulated activation of a postsynaptic receptor matrix after quantal release. They 
found that receptor activation progressively decreased with the increase of the cleft 
size, until the furthest limit of 300 nm. Moreover the density and spatial arrangement 
of receptors at the synapse are important determinants of the variability of receptor 
activation. According to Monte Carlo simulations, smaller, denser PSD are more 
efficacious than larger ones containing the same number of receptors, since the same 
amount of transmitter would be released over a reduced area. On the contrary, 
increase in the number of receptors (with constant density) requires increased PSD 
size and therefore reduces the average receptor efficacy for a given release event 
(Franks et al., 2003). It is also worth mentioning that the influence of PSD shape on 
the variability of synaptic currents has been addressed by including circular, 
rectangular and annular PSD (same area and the same receptor density) in Monte 
Carlo simulations of synaptic transmission. Interestingly, decreasing levels of receptor 
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open probability was achieved with the circular, rectangular and annular 
configurations, respectively, because of the increasing distance of the edge receptors 
from the release site (Franks et al., 2003). 
 
Liu, Current opinion in neurobiology (2003), 13:324-331 
2.5.3 Theoretical and experimental estimations of the agonist transient in the cleft 
Since most of the parameters responsible for the variability of GABAergic currents 
can significantly change in different synapses and only few of them can be accurately 
measured, the transmitter time course can be provided in terms of average behavior, 
bearing in mind the expected sources and effects of variability.  
The transmitter concentration dynamics in the cleft (agonist transient) has been 
estimated with theoretical and experimental approaches. Theoretical modeling 
consists of solving the Fick’s equation (Eq. 2) for the boundary conditions reflecting 
the geometry of the synapse or applying the Monte Carlo method that simulates the 
random movement of single neurotransmitter particles within the synapse. The 
application of the diffusion equation requires accurate estimations of the diffusion 
coefficients, of the radius of the cleft, corrections for the geometry of the synapse. 
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Therefore the lack of precise quantification of these parameters may represent a 
source of error in studying transmitter diffusion in the cleft. Kleinle et al. (1996) have 
quantified the impact of different release mechanisms (instantaneous or continuous 
release) and different diffusion constants on the dynamics of the transmitter 
concentration in the cleft. In the case of instantaneous release, it was found that, 
assuming a concentration of the transmitter in the vesicle of ~ 100 mM, the 
transmitter concentration at the post-synaptic side peaked at a very high concentration 
(18 mM) within 1 µs and declined to 10% of its value in 25 µs. In contrast when the 
continuous release was simulated (by introducing a release function calculated by 
Bruns & Jahn (1995), the release function peaked after ~ 100 µs and after ~ 0.5 ms 
declined to 50% of its maximum value. Including the release function in the diffusion 
process, the concentration of transmitter at the post-synaptic site was found to reach a 
peak value of 0.37 mM only after 250 µs and to decline to 10% of its maximum value 
after 2 ms. These simulations confirm that the rate of efflux of the transmitter from 
the vesicle is crucial for determining the transmitter concentration peak and time 
course seen by the post-synaptic receptors. In fact the rate of rise, the peak and the 
decay of the concentration of neurotransmitter in the cleft appear to be considerably 
different in the instantaneous or continuous release model. 
The dynamics of the transmitter in the cleft can be theoretically predicted also by 
using Monte Carlo simulation. This technique, although less accurate, is more 
versatile than the modeling based on Fick's equation. For a diffusion process 
occurring in one dimension, Monte Carlo simulation allows every transmitter 
molecule to perform 2 steps of length ∆x/2 in a time ∆t. After the time ∆t, the 
transmitter molecule has 50% probability to remain in the same place and 25% 
probability to be displaced both on the left and on the right side for the length ∆x. 
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Considering the x, y and z dimensions the diffusion process can be simulated in the 
space. The synaptic cleft space is thought to be divided in a grid of squared solids 
with dimension ∆x. Every step ∆t, a transmitter molecule can leave or remain in the 
squared solid according to a fixed probability. As in the Fick’s equation, also in 
Monte Carlo simulation a diffusion coefficient has to be defined. An interesting 
property of this approach is that, unlike equation modeling, the variability due to the 
stochastic nature of diffusion can be considered and quantified. In fact, since the 
number of molecules and the time steps are limited, starting from the same initial 
conditions, a trial-to-trial variability may occur. Assuming instantaneous release, 
Wahl et al. (1996) obtained results very similar to those observed with the approach 
based on the diffusion equation. In particular, they reported that the transmitter 
concentration peaked in few µs at a concentration of 12 mM and quickly decayed at 
the 10% of its maximum value in ~ 25 µs. Monte Carlo simulation appears to be 
adequate to study diffusion in complex geometry. 
In order to assess whether a given estimated transmitter concentration profile in the 
cleft can actually account for the experimental data on post-synaptic currents, these 
diffusion models were added with a kinetic model simulating the gating of the post-
synaptic receptors. Using either modeling (based on diffusion equation or Monte 
Carlo simulation), a peak concentration value > 0.37 mM and < 12 mM reached in < 
100 µs with a half-time fast clearance > 25 µs and < 2 ms seems to be a reasonable 
estimation of the transmitter concentration time course in the cleft. The theoretic 
modeling also shows that in addition to the reported fast clearance, a slower 
component is also present. The impact of this slower clearance component should 
strongly depend on the presence and the activity of the transmitter transporters. 
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The experimental approach for estimating the agonist transient in the cleft is based on 
artificially inducing an attenuation of synaptic currents. With a quantitative 
processing of the attenuation it is possible to infer the peak concentration and the time 
course of the synaptic agonist transient in the cleft. Recently allosteric modifiers of 
gating have been used to induce the attenuation of postsynaptic currents (Mozrzymas 
et al., 1999; Mozrzymas et al., 2003a). In particular, agents down regulating the 
binding rate (such as chlorpromazine or pH) turned out to be particularly useful. The 
main idea of such approach is that the reduction of the binding rate (by CPZ or acidic 
pH) requires a longer time of agonist exposure to achieve a complete binding. If the 
agonist transient is very fast, in the presence of modifiers of gating (CPZ or acidic 
pH) its duration becomes insufficient to complete the binding step. Thus, incomplete 
binding gives rise a to reduced current amplitude. It is worth noting that the shorter 
the agonist transient, the larger is the sensitivity of synaptic currents to reduction of 
the binding rate. On the contrary, for relatively slow clearance the considered 
modification of the binding rate gives rise to a very small change in current 
amplitude. A satisfactory reproduction of the attenuation induced by CPZ and pH was 
achieved by simulating the agonist concentration ~ 3 mM and a clearance time 
constant (τt)  ~ 100 µs, thus providing an estimation of the synaptic transient 
(Mozrzymas et al., 1999; Mozrzymas et al., 2003a).  Altogether these findings lead to 
the important conclusion that saturation of the receptors depends not only on the 
concentration of the transmitter in the cleft but also on the time duration of its 
clearance. 
An alternative experimental approach to estimate the concentration profile of 
neurotransmitter in the cleft is the use of low-affinity competitive antagonists. The 
rationale that sustains this approach relies on the comparable kinetics of the agonist 
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transient and the antagonists unbinding. In fact when post-synaptic receptors are pre-
equilibrated with a low-affinity (fast-off) competitive antagonist, the transmitter 
released would progressively displace the antagonist molecules from the binding site. 
If the duration of the synaptic agonist transient is comparable to that of the low-
affinity antagonist (non-equilibrium displacement) the displacement of the antagonist 
would generate a current flowing through the unblocked receptors, thus attenuating 
the effect of the antagonist. Since the displacement of the antagonist (and the degree 
of attenuation) depends on both the transmitter concentration and the time it lasts in 
the cleft, with model simulations it is possible to infer the properties of the transmitter 
transient. Therefore a longer permanence and/or a higher concentration of transmitter 
in the cleft will reduce the antagonist-induced attenuation. On the contrary, at low 
transmitter concentrations and/or brief transients, a large attenuation is expected. This 
method was first applied to study the dynamics of glutamate concentration in the cleft 
by using low-affinity competitive antagonist for NMDA, receptors D-aminoadipate 
(D-AA) (Clements et al., 1992; Clements, 1996). More recently, the method based on 
the use low-affinity antagonist has been applied to give a quantification of the 
variability of glutamate transient in the cleft and to correlate it with the variability of 
AMPA-mediated mEPSCs (Liu et al., 1999). 
With a similar approach it was also possible to estimate the time course of agonist at 
GABAergic synapses (Overstreet et al., 2002). The use of SR95531 as a fast-off 
competitive antagonist of GABAA receptors allowed concluding that synaptic GABA 
peaks at 3-5 mM and is cleared out within 300-600 µs. To our knowledge the 
fluctuations of GABA transient in the cleft and the influence of this variability on 
GABA-mediated mIPSCs have never been specifically addressed, thus the study 
reported in this thesis it the first attempt in that direction. 
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2.6 GABAA receptor clustering 
Clustering of neurotransmitter receptors at the postsynaptic membrane is a critical 
requirement for efficient synaptic transmission. For instance defects in GABAA 
receptor clustering are associated with cellular dysfunction and anxiety disorders in 
mice (Crestani et al., 1999). Neurotransmitter receptor clustering appears to be 
mediated by a number of intracellular proteins that can, either individually or as part 
of multiprotein complexes, physically link the membrane-localized receptors to the 
cytoskeleton (Colledge & Froehner, 1998; Moss & Smart, 2001). Currently the best 
understood clustering machinery is the one relative to glutamate receptors (reviewed 
in Bolton et al. (2000). On the contrary although several proteins have been identified 
to be directly or indirectly involved in the sorting, trafficking, synaptic targeting and 
clustering of GABAA receptors, until now little is known about the molecular 
mechanisms that concentrate GABAA receptors in the postsynaptic membrane (Coyle 
& Nikolov, 2003).  
 
Kneussel M. Brain Res Brain Res Rev. (2002) Jun;39(1):74-83 
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A well-assessed requirement for the clustering of virtually all GABAA receptor 
subtypes is the presence of the γ2 subunit. In fact Essrich et al. (1998) found that, in 
primary cultures from cerebral cortex of γ2-/- mice there was a strong reduction of the 
puntuate staining of GABAA receptors. Similarly, the deletion of the γ2 subunit with 
the Cre-loxP strategy resulted in the loss of benzodiazepine-binding sites and parallel 
loss of punctate immunoreactivity of postsynaptic GABAA receptors in the 
hippocampus (Schweizer et al., 2003).  
It has also been reported that the clustering of GABAA receptors is associated with 
gephyrin, a tubulin-binding protein known to directly anchor glycine receptors to the 
cytoskeleton (Kirsch & Betz, 1995; Feng et al., 1998; Crestani et al., 1999; Meier & 
Grantyn, 2004; Sola et al., 2004).  In particular gephyrin is thought to be involved in 
the stabilization of GABAA receptor clusters at the membrane (Sassoe-Pognetto 
2000), although not in the direct anchoring, since efforts to demonstrate a direct 
interaction of gephyrin with GABAAR have failed (Meyer et al., 1995; Kannenberg et 
al., 1997).  
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In favor of a gephyrin-mediated stabilization of GABAA receptor clusters it has been 
reported that, in wild type mice, GABAA receptor clusters colocalized with gephyrin 
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clusters (Christie et al., 2002a; Schweizer et al., 2003; Danglot et al., 2003), while in 
mice lacking γ2 subunit there was a significant reduction of gephyrin puncta (Essrich 
et al., 1998). Further evidence for the involvement of gephyrin in mediating the 
stabilization of GABAA receptor clusters came from the decrease in the punctate 
staining of the γ2 and the α2 subunits after the inhibition of gephyrin synthesis in 
cortical neurons with anti-sense oligonucleotides (Essrich et al., 1998). The final 
demonstration of a gephyrin-dependent stabilization of GABAA receptor clusters 
came from the total loss of postsynaptic γ2- and α2-subunit immunoreactivity 
observed in spinal cord sections and hippocampal neurons of gephyrin knock-out 
mice (Kneussel et al., 1999). Notably in the absence of gephyrin the number of 
functional GABAA receptors was only marginally reduced, while that of intracellular 
microclusters was increased (Kneussel et al., 1999). These observations indicate that 
gephyrin is important both for receptor localization and stabilization (or “non-direct 
anchoring”) at postsynaptic sites (Kneussel & Betz, 2000). Speculations on the 
anchoring of GABAA receptors can be put forward from a model for GlyR 
anchoring/clustering recently proposed (Sola et al., 2004). This model relies on the 
ability of trimeric gephyrin to dimerize upon appropriate stimulus and potentially 
form a hexagonal network that could mediate GlyR clustering. Combining this 
hypothesis with the recent evidence of a PKC-enhanced preferential accumulation of 
GABAA receptor γ2 subunit intracellular loop at inhibitory synapses in association 
with gephyrin (Meier 2004) opens the possibility of undiscovered interactions, which 
could potentially account for the direct anchoring of GABAA receptors. Nevertheless 
it is worth noting that a gephyrin independent clustering has been identified (Kneussel 
et al., 2001; Levi et al., 2004; Fritschy et al., 2003). In fact clusters of different types 
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of GABAA receptors could still be detected in gephyrin knock out mice, suggesting 
that an alternative mechanism for GABAA receptor clustering must exist. 
An intriguing protein found after using the yeast two-hybrid approach to search for 
interactors of the GABAA receptor γ2 subunit is GABARAP (GABAA receptor-
associated protein). This protein not only shows tubulin binding activity (Wang & 
Olsen, 2000) but also interacts with the γ2 subunit of GABAA receptors (Wang et al., 
1999) and binds a truncated form of gephyrin (Kneussel et al., 2000).  
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Its colocalization with surface GABAA receptors and gephyrin first suggested that 
GABARAP could be a putative anchoring protein located beneath the plasma 
membrane (Wang et al., 1999; Wang & Olsen, 2000; Kneussel et al., 2000). Recently 
several studies have demonstrated that GABARAP is rarely found beneath the 
membrane, rather the majority of GABARAP puncta are located in intracellular 
compartments such as putative ER and Golgi structures (Kneussel et al., 2000; 
Okazaki et al., 2000; Kittler et al., 2001) thus rising the possibility that this protein is 
mainly involved in receptor trafficking. However it is worth noting that receptor 
trafficking includes several mechanisms such as the assembly of subunits into 
functional receptors, targeting to synaptic or extrasynaptic membranes, endocytosis, 
recycling and degradation (Coyle & Nikolov, 2003). The possible role of GABARAP 
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in GABAA receptors trafficking is strengthened by its sequence and structural 
similarities with mammals and yeast proteins involved in membrane dynamics and 
vesicular transport such as Golgi-associated ATPase enhancer (GATE-16, (Sagiv et 
al., 2000), Apg8p/Aut7 (Lang et al., 1998; Kirisako et al., 1999), MAP1B (Passafaro 
& Sheng, 1999; Wang et al., 1999). Moreover GABARAP also binds N-
ethylmalemide sensitive factor (NSF), a protein that plays an essential role in 
intracellular membrane trafficking events (Rothman, 1994) and ULK-1 (Okazaki et 
al., 2000), an Unc-51-like serine-threonine kinase involved in neurite extension. All 
together these evidences suggest that GABARAP could be specialized to recruit 
GABAA receptors into vesicles targeted to and from the postsynaptic membrane 
(Kneussel, 2002).  
Whatever is the precise function of GABARAP in GABAA receptor dynamics, it 
seems that its final effect is to promote GABAA receptor clustering, even though the 
native protein poorly colocalyzed with synaptic clusters of GABAAR (Kneussel et al., 
2000; Kittler et al., 2001). In fact there is compelling evidence that coexpression of 
GABARAP with subunits of GABAA receptors does result in increased clustering of 
recombinant receptors in many cells (Chen et al., 2000; Everitt et al., 2004). An effort 
to reconcile coexpression studies with in vivo localization of GABARAP has been 
made recently. From the structural studies on GABARAP (Knight et al., 2002; Coyle 
et al., 2002), Phillips & Froehner (2002) speculated that polymerized forms of 
GABARAP bound to γ2 subunit, to tubulin and possibly to gephyrin can have such a 
packed structure that becomes inaccessible to antibody probes. This can be the reason 
why GABARAP was almost undetectable beneath the membrane with traditional 
immunofluorescence methods (Kneussel et al., 2000; Kittler et al., 2001). 
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Another essential requirement for proper receptor clustering is the intact cytoskeleton 
(Chen et al., 2000). In fact the depolymerization of microtubules with nocodazole 
impaired the clustering of recombinant GABAA receptors in QT6 cells and seemed to 
affect receptor function (Wang & Olsen, 2000; Chen et al., 2000). 
The evidence of the essential role of the cytoskeleton in allowing neurotransmitter 
receptor clustering was also demonstrated by the loss of postsynaptic gephyrin and 
glycine receptor clusters in cultured neurons after treatment with alkaloids that 
destroy microtubules (Kirsch & Betz, 1995; Sheng & Pak, 2000).  
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3. Methods 
3.1 Cell culture 
Hippocampal cell culture was prepared according to the method previously described 
by Andjus et al. (1997). Briefly, Hippocampi were taken from postnatal day 2 (P2)–
P4 Wistar rats after being anesthetized with an intraperitoneal injection of urethane (2 
gm/kg). This procedure is in accordance with the regulation of the Italian Animal 
Welfare Act and was approved by the local authority veterinary service. Hippocampi 
were dissected free, sliced, and digested with trypsin, mechanically triturated, 
centrifuged twice at 40 X g, plated in the Petri dishes, and cultured for up to 14 d. 
Experiments were performed on cells cultured for at least 7 days.  
 
3.1 Nocodazole treatment 
Nocodazole (purchased from Sigma, Milano, Italy) was used to disrupt microtubules. 
It was applied at the concentration of 10 µg/ml (Bueno & Leidenheimer, 1998) from a 
100% Dimethyl Sulfoxide (DMSO) stock solution. The final concentration of DMSO 
in the working solutions was 0.1% (v/v). Nocodazole was applied in two different 
ways: in the culture medium (bath treatment) and via the patch pipette (intrapipette 
application).  Bath treatment consisted of adding the drug to the neuronal culture 
medium and incubating the cells at 37° C for 2 hours. In order to verify whether 
DMSO alone could affect GABAergic transmission, some electrophysiological 
experiments were performed also on cells incubated for 2 hours with DMSO alone. 
DMSO 0.1% (v/v) did not produce any change in the kinetic properties of miniature 
inhibitory synaptic Intrapipette application consisted of adding nocodazole to the 
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intracellular solution in order to apply the drug only to the recorded cell via the patch 
pipette (Meyer et al., 2000; van Zundert et al., 2002). 
 
3.2 Immunofluorescence 
Immunofluorescence labeling of surface antigens was performed before fixation, by 
incubating living neurons for 15 minutes at 4oC with primary affinity-purified rabbit 
polyclonal antibody raised against the δ subunit (1-44 region) and  γ2 subunits (1-33 
region) of GABAA receptors.  The antibodies, kindly provided by Prof. W. Sieghart 
(University of Wien, Austria), were diluted in the external solution (also used in 
electrophysiology experiments; in mM: NaCl 137, KCl 5, CaCl2 2, MgCl2 1, glucose 
20, and HEPES 10, pH 7.4, with NaOH) supplemented with 0.1% BSA (Sigma). 
After washing in the same medium, hippocampal neurons were fixed in 4% 
paraformaldehyde-4% sucrose (w/v) in PBS, blocked with 10% normal serum and 
sequentially incubated with FITC-labeled goat anti-rabbit IgG or biotinylated goat 
anti-rabbit IgG followed by FITC-labeled streptavidin. In order to decorate 
intracellular antigens such as microtubules and the presynaptic marker, 
immunocytochemistry for tubulin and synaptophysin was performed on the same 
hippocampal neurons. Cells were therefore permeabilized with 0.1% NP40, washed 
with PBS, blocked with 10% normal serum, and incubated with a in house polyclonal 
antibody against tubulin (rat) and a monoclonal mouse anti-synaptophysin antibody 
(Chemicon). The resulting immune complexes were incubated for 1 hour at room 
temperature with appropriate secondary antibodies conjugated with different 
fluorophores (i.e., TRICT-labeled rabbit anti-rat IgG or TRITC-labeled rabbit anti-
mouse IgG). All secondary antibodies were from Sigma (Milano, Italy). These 
experiments were performed both on untreated and on nocodazole-treated neurons.  
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Since it is known that the microtubular network is temperature sensitive (Machu, 
1998) immunocytochemical experiments were performed in parallel at room 
temperature and at 4oC in order to verify cytoskeleton integrity after in vivo labeling.  
Speciments were observed with a 63X oil immersion objective, followed by a 2X and 
4.5X digital zoom magnification. Images were acquired on an Olympus (BX51WI) 
confocal system by using sequential dual channel recording of double-labeled cells.  
 
3.3 Electrophysiological recordings  
Currents were recorded in the whole-cell, excised-patch and nucleated-patch 
configurations of the patch-clamp technique using an EPC-7 amplifier (List Medical, 
Darmstadt, Germany). The stability of the patch was checked by repetitively 
monitoring the input and series resistance during the experiments. Cells exhibiting 
more than 15% changes during the experiment were excluded from the analysis. The 
series resistance (Rs) was 4 - 8 MΩ and it was compensated by 70 – 80 %. All the 
experiments were performed at room temperature (22–24°C). The intrapipette 
solution contained (in mM): CsCl 137, CaCl2 1, MgCl2 2, 1,2-bis(2-
aminophenoxy)ethane-N,N,N’,N’-tetra-acetic acid (BAPTA) 11, ATP 2, and HEPES 
10, pH 7.2 with CsOH. The composition of the external solution was (in mM): NaCl 
137, KCl 5, CaCl2 2, MgCl2 1, glucose 20, and HEPES 10, pH 7.4, with NaOH.  
During whole-cell recordings the holding potential was -70 mV. The external solution 
was supplemented with tetrodotoxin (TTX; 1 µM), kynurenic acid (1 mM) and CGP 
55845 (1 µM), to block voltage activated Na+ channels, ionotropic glutamate 
receptors and GABAB receptors, respectively. In some cases tetrodotoxin (TTX) 
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omitted from the solution in order to allow action potentials to occur and thus promote 
a larger release of GABA.  
In the excised-patch and nucleated-patch configurations the holding voltage was –70 
mV and – 30 mV, respectively. 
Currents were sampled at 50–100 kHz, digitized, low-pass filtered at 3.15 kHz with a 
Butterworth filter and stored on the computer hard disk. The acquisition softwares 
used were Clampex 9 (Axon Laboratory) and WCP, kindly given by Dr. J. Dempster 
(Strathclyde University, Glasgow, UK). Since it has been previously observed that the 
amplitude of tonic GABAergic currents in the hippocampus can be reduced when the 
cells are perfused with a stream of saline (Valeyev et al., 1993; Bai et al., 2001), 
except otherwise stated our experiments were performed with a constant low 
perfusion rate. 
Two different perfusion systems for drug applications were used: the multibarrel 
RSC-200 perfusion system (Bio-Logic, Grenoble, France) and the ultrafast system 
based on the use of a piezoelectric-driven theta glass application pipette (Colquhoun et 
al., 1992). The head of the multibarrel system was positioned close to the soma of 
neurons either to evoke whole-cell GABA-induced currents or to exchange drug-
containing solutions around the cell from which synaptic activity was recorded in the 
whole-cell configuration. The time course of the solution exchange was estimated by 
liquid junction potential measurements. The application of a 10%-diluted external 
solution to the open tip patch pipette evoked a junctional current. The establishment 
of this current represents the complete solution exchange around the patch pipette. 
The 10-90% of this process occurred within 10-20 msec (10-90% solution exchange 
time). A better indication of the exchange time around the cell was given by the rise 
time of whole-cell responses evoked by high concentrations of GABA (>1 mM). 
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Since it is known that with such high concentrations of GABA the rise time of the 
current responses is less than or close to 1 msec the observed rise time of the whole-
cell current (15-30 msec) was mainly determined by the speed of the solution 
exchange. 
The piezoelectric translator used for ultrafast perfusion system was from Physik 
Instrumente (Waldbronn, Germany), and theta glass tubing was from Hilgenberg 
(Malsfeld, Germany). Judging from the onset of the liquid junction potentials, the 10-
90% solution exchange time was 40-80 µsec. The speed of the solution exchange was 
also estimated around the excised patch by the 10-90 % onset of the membrane 
depolarization induced by application of high (25 mM) potassium saline. In this case 
the 10-90 % rise time value (60-90 µs) was very close to that found for the open tip 
recordings. 
 
From Jonas P., Single Channel Recording. Ple
 
3.4 Drugs 
Picrotoxin and CGP 55845 were purchased from Tocris 
purchased from Molecular Probes (Leidens, The Netherlan
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were purchased from Sigma (Milano, Italy). 
 
 
3.5 Data Analysis  
Synaptic currents were analyzed with the AxoGraph 4.9 program (Axon Instruments, 
Foster City, CA). This program uses a detection algorithm based on a sliding 
template. The template did not induce any bias in the sampling of events since it was 
moved along the data trace one point at a time and was optimally scaled to fit the data 
at each position. The detection criterion was calculated from the template scaling 
factor and from how closely the scaled template fitted the data. The threshold for 
detection was set at 3.5 times the standard deviation of the baseline noise. Using the 
same program, the rise time of averaged mIPSCs was estimated as the time needed for 
10 to 90 % increase of the peak current response and the decay time constants were 
taken from multiexponential fit of the decay. 
Deactivation time courses of mIPSCs and GABA-evoked currents were fitted with a 
sum of two and three exponentials, respectively. 
      Ai * exp( - t / τi), ∑
=
=
n
i 1
  y(t)                         (1) 
where, Ai are the fractions of respective components, τi are the time constants and 
As is the steady-state current. 
In the case of analysis of normalized currents, the fractions of kinetic components 
fulfilled the normalization condition: 
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     ∑ Ai  = 1.  
=
n
i 1
                            (2) 
The decaying phase of the currents was also estimated using the τmean defined as:  
     τmean =  Ai * τi, ∑
=
n
i 1
                                (3) 
where Ai and τi are respectively the relative fraction and time constant of the different 
components. 
The desensitization onset was described by:  
     y(t) = Afast * exp( - t / τfast) + Aslow * exp( - t / τslow) + As (4) 
where Afast and Aslow are the fractions of the fast and the slow component, respectively, 
τfast and τslow are the fast and the slow time constants and As is the steady state current.  
Brief (1-2 ms) paired pulses separated by a variable time interval (paired-pulse 
protocols) were used to test whether or not the entrance of bound receptors into the 
desensitised state proceeded after the agonist removal. The parameter R was 
calculated according to the formula:  
     
end
end
II
IIR −
−=
1
2  (5) 
where I1 is the first peak amplitude, Iend is the current value immediately before the 
application of the second pulse, I2 is the second peak amplitude. During 1-2 ms pulse 
the onset of the use-dependent desensitization is minimal. Thus, in the case of 
continued entrance into the desensitized state after the first short agonist pulse, the 
peak of the second response (I2) was smaller than the first one resulting in R < 1.  
The goodness of the fit was assessed by minimizing the sum of the squared 
differences. 
The amplitude of the tonic current was estimated by the outward shift of the baseline 
current after the application of the GABAA receptor antagonists bicuculline (100 µM) 
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or picrotoxin (100 µM) (Wall & Usowicz, 1997). Four epochs of 500 ms each, were 
pooled together to calculate the baseline current amplitude and its standard deviation. 
The resulting all-point histogram was fitted with a Gaussian function. Only current 
recordings that exhibited a stable baseline were included in the analysis. During the 
experiments in the whole cell configuration spontaneous inhibitory postsynaptic 
currents (IPSCs) were recorded but were avoided during the analysis of tonic currents. 
The analysis of the variance of the baseline current (σ2) allowed estimating the single 
channel current (i) and the single channel conductance (γ) of the receptors mediating 
tonic currents (I) (Valeyev et al., 1993; Bai et al., 2001; Wisden et al., 2002; Yeung et 
al., 2003).  
Plotting σ2 vs I gives rise to a parabolic function 
     σ2 =  i (1 - Po) I (6) 
where Po is the channel open probability which varies from 0 to 1. Assuming that at 
extremely low concentrations of GABA (0.1 – 1 µM) the open probability of the 
channels mediating tonic currents is extremely small, a simplified eq. (6) suggests that 
     i = σ2 / I                                  (7) 
However in the presence of GABAA receptor antagonist there is still a variance in the 
baseline current (σ2bic). Therefore eq. (7) must be adjusted for the intrinsic variability 
of tonic currents: 
     i = (σ2 - σ2bic) / I                                   (8) 
Single channel conductance of the receptors mediating tonic currents was estimated 
with the following equation: 
     γ = I / (Vm – ECl-)                                   (9) 
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where  Vm is the holding potential and ECl- is the reversal potential of Cl- (in our 
experimental conditions these values were approximately -70 mV and 0 mV).  
Data are expressed as mean ± SEM, and all the values included in the statistics 
represent recordings from separate cells. Statistical comparisons were made with the 
use of paired and unpaired t test, Wilcoxon signed rank test and Kolmogorov-Smirnov 
test (p < 0.05 was taken as significant). 
 
3.6 Kinetic model simulations  
The kinetic modelling was performed with the ChanneLab2 software (Synaptosoft 
Inc, Synaptosoft Inc., USA). The ChanneLab2 software converted the kinetic model 
into a set of differential equations and solved them numerically. Since in the absence 
of agonist, receptors can spontaneously open at very low probability (Birnir et al., 
2000; Birnir et al., 2001; Bianchi & Macdonald, 2001), for simulation convenience it 
was assumed as initial condition, i.e. at t = 0, no bound or open receptors were 
present. Various experimental protocols were investigated by “clamping” the agonist 
concentration time course in the form of square-like pulses (ultrafast perfusion 
experiments). The solution of such equations yielded the time courses of probabilities 
of all the states assumed in the model. The fit to the experimental data was performed 
by optimizing the values of rate constants to reproduce the current time course for a 
given experimental protocol. The procedure for the rate constants optimization was 
based on the comparison of the time course of recorded currents and that of simulated 
responses.  
The model chosen for the simulations was that proposed by Jones & Westbrook (1995) 
(see Introduction, ch 2.4.4). The quality of the fit was assessed by measuring the relative 
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distance (RD) of the investigated parameter (e.g. current rise time or amplitude) from 
that in the model prediction:  
     ∑
=
−=
n
i
ii myAbsn
RD
1
)(1                                    (10) 
where n is the number of data points, yI is the experimentally measured value, mi is the 
model prediction and Abs(x) is the absolute value function.  
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Summary 
Tonic inhibition plays a crucial role in regulating neuronal excitability since it sets the 
threshold for action potential generation and integrates excitatory signals. Tonic 
currents are known to be largely mediated by extrasynaptic GABAA receptors that are 
persistently activated by submicromolar concentrations of ambient GABA. Recently 
we have reported that, in cultured hippocampal neurons, the clustering of synaptic 
GABAA receptors significantly affects synaptic transmission. In the present work we 
have demonstrated that the clustering of extrasynaptic GABAA receptor modulates 
tonic inhibition. The depolymerization of the cytoskeleton with nocodazole promoted 
the disassembly of extrasynaptic clusters of δ and γ2 subunit-containing GABAA 
receptors. This effect was associated with a reduction in the amplitude of tonic 
currents and a diminished shunting inhibition. Moreover diffuse GABAA receptors 
were less sensitive to the GAT-1 inhibitor NO-711 and to flurazepam. A quantitative 
analysis of GABA-evoked currents after a prolonged exposure to submicromolar 
concentrations of GABA and model simulations suggest that clustering affects the 
gating properties of extrasynaptic GABAA receptors. In particular a larger occupancy 
of the singly- and doubly- bound desensitized states can account for the modulation of 
tonic inhibition recorded after nocodazole treatment. Moreover the comparison 
between tonic currents recorded during spontaneous activity and those elicited by 
exogenously applied low concentrations of agonist allow estimating the concentration 
of ambient GABA. In conclusion receptor clustering appears to be an additional 
regulating factor for tonic inhibition. 
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Introduction 
Similarly to many other neurotransmitter receptors, GABAA receptors are localized at 
synaptic and extrasynaptic level. While synaptic GABAA receptors are involved in 
phasic inhibition (1), extrasynaptic ones are responsible for tonic inhibition (2-9). 
Tonic inhibition is due to a persistent inhibitory conductance that contributes to 
“signal integration” in the brain, since it sets the threshold for action potential 
generation (10, 11) and shunts excitatory synaptic inputs (2, 12-15). This conductance 
is maintained by “ambient” GABA, which represents the amount of neurotransmitter 
present in the extracellular space. “Ambient” GABA originates from spillover of the 
neurotransmitter released at neighboring synapses (3, 5, 11), from astrocytes (16, 17) 
or from non-vesicular release (18, 19). Tonic inhibition has been well characterized in 
the cerebellum where α6 subunit-containing receptors act as high affinity sensors for 
GABA (4, 11, 20, 21). A persistent GABA conductance has been identified also in 
other brain regions, including the hippocampus (6, 8, 9, 22, 23). However, in this 
structure the subunits composition of the receptors involved has not been fully 
elucidated. In the past years immunocytochemical and in situ hybridization 
approaches (20, 24-26) have demonstrated that GABAA receptors are clustered not 
only at synaptic but also extrasynaptic level. However, at present the influence of the 
clustering of extrasynaptic GABAA receptors on tonic current is still unclear while it 
is well established that clustering of synaptic receptors ensures proper synaptic 
signaling. In line with a previous study (27), here we have pharmacologically induced 
the declusterization of GABAA receptors by means of nocodazole, a microtubule 
disrupting agent and we have analyzed tonic inhibition in cultured hippocampal 
neurons. With immunocytochemical experiments we found clusters of δ subunit-
containing GABAA receptors exclusively at extrasynaptic locations, while clusters of 
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γ2 subunit-containing receptors were detectable either at synaptic and extrasynaptic 
sites. Nocodazole treatment induced the disassembly of all the clusters, thus 
promoting a uniform distribution of δ− and γ2- containing GABAA receptors on the 
cell surface. This effect was associated with a reduced tonic current. Moreover, 
diffuse GABAA receptors were less sensitive to the GAT-1 inhibitor NO-711 and to 
flurazepam (FZP). Model simulations suggest that a larger occupancy of singly bound 
desensitized state of declustered receptors may account for the reduction of the tonic 
current after nocodazole treatment. 
 
 72
Experimental Procedures 
Cell culture 
Hippocampal cell cultures were prepared as previously described (28). Briefly, 2-4 
days old (P2-P4) Wistar rats were decapitated after being anesthetized with an 
intraperitoneal injection of urethane (2 mg/kg). This procedure is in accordance with 
the regulation of the Italian Animal Welfare Act and was approved by the local 
authority veterinary service. Hippocampus were dissected free, sliced, and digested 
with trypsin, mechanically triturated, centrifuged twice at 40 x g, plated in Petri 
dishes, and cultured for up to 14 days. Experiments were performed on cells cultured 
for at least 7 days. 
 
Nocodazole treatment  
Nocodazole (purchased from Sigma, Milano, Italy) was used to disrupt microtubules. 
It was applied at the concentration of 10 µg/ml (29) from a 100% Dimethyl Sulfoxide 
(DMSO) stock solution. The final concentration of DMSO in the working solutions 
was 0.1% (v/v). Nocodazole treatment consisted of incubating the neurons with the 
drug for at least 2 hours in the culture medium. In order to verify whether DMSO 
alone could affect GABAergic transmission, some electrophysiological experiments 
(n = 12) were performed also on cells incubated for 2 hours with DMSO alone. 
DMSO 0.1% (v/v) did not produce any change in the kinetic properties of miniature 
inhibitory synaptic currents (data not shown).  
 
Immunofluorescence staining and confocal microscopy 
Immunofluorescence labeling (30) of surface GABAA receptor δ and γ2 was 
performed before fixation, first by incubating living neurons for 15 minutes at 4oC 
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with affinity-purified rabbit polyclonal antibodies raised against the extracellular 
amino terminal region of the corresponding subunits (i.e. 1-44 region of the δ subunit 
and 1-33 region of the γ2 subunit), diluted in the external solution (also used in 
electrophysiological experiments; in mM: NaCl 137, KCl 5, CaCl2 2, MgCl2 1, 
glucose 20, and HEPES 10, pH 7.4, with NaOH) supplemented with 0.1% BSA 
(Sigma). After washing in the same medium, hippocampal neurons were fixed in 4% 
paraformaldehyde-4% sucrose (w/v) in PBS, blocked with 10% normal serum and 
sequentially incubated with biotinylated goat anti-rabbit IgG followed by FITC-
labeled streptavidin. To evaluate the synaptic and extrasynaptic distribution of 
GABAA receptors, immunocytochemistry for synaptophysin was performed on the 
same hippocampal neurons. Cells were therefore permeabilized with 0.1% NP40, 
washed with PBS, blocked with 10% normal serum, and incubated with a monoclonal 
anti-synaptophysin antibody (Chemicon). The resulting immune complexes were 
visualized with TRITC-labeled rabbit anti-mouse IgG (Sigma, Milano, Italy). All 
secondary antibodies were from Sigma (Milano, Italy). These experiments were 
performed both on untreated and on nocodazole-treated neurons. 
Since it is known that the microtubular network is temperature sensitive (31) some 
control experiments were performed in parallel to our main immocytochemical 
analysis in order to verify the cytoskeleton integrity after in vivo labeling.  Briefly, the 
same protocol described above was followed with the exception that, after 
permeabilization, a rat anti-tubulin monoclonal antibody was used instead of 
synaptophysin.  Confocal analysis performed on these neurons demonstrated that the 
typical branched microtubular bundles were intact after in vivo labeling and 
comparable with similar experiments performed at room temperature (data not 
shown). Moreover the same type of control experiments were also performed on 
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nocodazole treated neurons in order to verify the expected (27) drug induced 
depolymerization of the microtubules (data not shown).  
Speciments were observed with a 63X oil immersion objective, followed by a 2X and 
4.5X digital zoom magnification. Images were acquired on a Olympus (BX51WI) 
confocal system by using sequential dual channel recording of double-labeled cells.  
 
Electrophysiological recordings 
Currents were recorded in the whole-cell and nucleated-patch configurations of the 
patch-clamp technique using an EPC-7 amplifier (List Medical, Darmstadt, 
Germany). The stability of the patch was checked by repetitively monitoring the input 
and series resistance during the experiments. Cells exhibiting more than 15% changes 
during the experiment were excluded from the analysis. The series resistance (Rs) was 
5 - 7 MΩ and it was compensated by 70 – 80 %. All the experiments were performed 
at room temperature (22–24°C). The intrapipette solution contained (in mM): CsCl 
137, CaCl2 1, MgCl2 2, 1,2-bis(2-aminophenoxy)ethane-N,N,N’-tetra-acetic acid 
(BAPTA) 11, ATP 2, and HEPES 10, pH 7.2 with CsOH. The composition of the 
external solution was (in mM): NaCl 137, KCl 5, CaCl2 2, MgCl2 1, glucose 20, and 
HEPES 10, pH 7.4, with NaOH. During whole-cell recordings the holding potential 
was -70 mV. The external solution was supplemented with tetrodotoxin (TTX; 1 µM), 
kynurenic acid (1 mM) and CGP 55845 (1 µM), to block voltage activated Na+ 
channels, ionotropic glutamate receptors and GABAB receptors, respectively. In some 
cases tetrodotoxin (TTX) omitted from the solution in order to allow action potentials 
to occur and thus promote a larger release of GABA. Currents were sampled at 50–
100 kHz, digitized, low-pass filtered at 3.15 kHz with a Butterworth filter and stored 
on the computer hard disk. The acquisition softwares used were Clampex 9 (Axon 
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Laboratory) and WCP, kindly given by Dr. J. Dempster (Strathclyde University, 
Glasgow, UK). Control and drug-containing solutions were delivered to the recorded 
neurons with a perfusion systems consisting of glass barrels positioned close to the 
soma of the recorded cell (multibarrel RSC-200 perfusion system, Bio-Logic, 
Grenoble, France). Judging from the onset of the liquid junction potentials, a 
complete exchange of the solution around the open-tip electrode occurred within 10–
20 msec. 
Since it has been previously observed that the amplitude of tonic GABAergic currents 
in the hippocampus can be reduced when the cells are perfused with a stream of saline 
(6, 32), our experiments were performed with a constant low perfusion rate. However 
in the experiments with NO-711, the perfusion was turned off in order to allow a 
larger accumulation of GABA. The drug was first injected into the recording chamber 
through the glass barrels previously described. After the recording solution was 
completely replaced by the NO-711-containing solution (around 4 min), the perfusion 
system was turned off in order to avoid that the stream of fluids partially diffused 
away ambient GABA. 
Picrotoxin and CGP 55845 were purchased from Tocris (Bristol, UK). Flurazepam 
was a kind gift of Dr.Vicini. All the other drugs were purchased from Sigma (Milano, 
Italy). 
In nucleated patch configuration the holding voltage was –30 mV. GABA-containing 
solutions were applied to nucleated patches using an ultrafast perfusion system based 
on piezoelectric driven theta-glass application pipette (33). The piezoelectric 
translator was from Physik Instrumente (Waldbronn, Germany), and theta glass tubing 
was from Hilgenberg (Malsfeld, Germany). The open tip recordings of the liquid 
junction potentials revealed that the 10–90% exchange of the solution occurred within 
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40–80 µsec. The speed of the solution exchange was also estimated around the 
excised patch by the 10–90% onset of the membrane depolarization induced by 
application of high (25 mM) potassium saline. In this case the 10–90% rise time value 
(60–90 µsec) was very close to that found for the open tip recordings.  
 
Data analysis 
The amplitude of the tonic current was estimated by the outward shift of the baseline 
current after the application of the GABAA receptor antagonists bicuculline (100 µM) 
or picrotoxin (100 µM) (1). Four epochs of 500 ms each, were pooled together to 
calculate the baseline current amplitude and its standard deviation. The resulting all-
point histogram was fitted with a Gaussian function. Only current recordings that 
exhibited a stable baseline were included in the analysis. During the experiments in 
the whole cell configuration spontaneous inhibitory postsynaptic currents (IPSCs) 
were recorded. In particular depending on the presence or the absence of TTX, 
spontaneous miniature (mIPSCs) or action potential-dependent synaptic (sIPSCs) 
GABAergic currents were identified. Synaptic currents were analyzed with the 
AxoGraph 4.9 program (Axon Instruments, Foster City, CA). This program uses a 
detection algorithm based on a sliding template. The template did not induce any bias 
in the sampling of events because it was moved along the data trace one point at a 
time and was optimally scaled to fit the data at each position. The detection criterion 
was calculated from the template-scaling factor and from how closely the scaled 
template fitted the data. The threshold for detection was set at 3.5 times the SD of the 
baseline noise. Using the same program, the decay time constant of averaged mIPSCs 
was taken from the biexponential fit of the decay time.  
The decaying phase of the IPSCs was fitted with exponential functions in the form: 
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∑
=
=
n
i 1
  y(t) Ai * exp( - t / τi),                                                                            (1) 
where τi and Ai are the time constants and relative fractions of the respective 
components.  
In the case of analysis of normalized currents, the fractions of kinetic components 
fulfilled the normalization condition: 
 ∑ Ai  = 1.           (2) 
=
n
i 1
The deactivation time courses of IPSCs was fitted with the sum of two exponentials 
(n=2). 
The mean time constant, calculated as: 
 τmean =  Ai * τi,          (3) ∑
=
n
i 1
 
was used to estimate the speed of the decaying process.  
The goodness of the fit was assessed by minimizing the sum of the squared 
differences. 
The analysis of the variance of the baseline current (σ2) allowed estimating the single 
channel current (i) and the single channel conductance (γ) of the receptors mediating 
tonic currents (I) (6, 32, 34, 35).  
Plotting σ2 vs I gives rise to a parabolic function 
σ2 =  i (1 - Po) I         (4) 
where Po is the channel open probability which varies from 0 to 1. Assuming that at 
extremely low concentrations of GABA (0.1 – 1 µM) the open probability of the 
channels mediating tonic currents is extremely small, a simplified eq. (4) suggests that 
i = σ2 / I          (5) 
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However in the presence of GABAA receptor antagonist there is still a variance in the 
baseline current (σ2bic). Therefore eq. (5) must be adjusted for the intrinsic variability 
of tonic currents: 
i = (σ2 - σ2bic) / I         (6) 
Single channel conductance of the receptors mediating tonic currents was estimated 
with the following equation: 
γ = I / (Vm – ECl-)        (7) 
where  Vm is the holding potential and ECl- is the reversal potential of Cl- (in our 
experimental conditions these values were approximately -70 mV and 0 mV).  
Data are expressed as mean ± SEM, and all the values included in the statistics 
represent recordings from separate cells. Statistical comparisons were made with the 
use of paired and unpaired t test, Wilcoxon signed rank test and Kolmogorov-Smirnov 
test (p < 0.05 was taken as significant). 
 
Model simulations 
Simulation experiments were performed using the ChanneLab2 software 
(Synaptosoft). The ChanneLab2 software converted the kinetic model (see Fig. 8A) 
into a set of differential equations and solved them numerically. Since in the absence 
of agonist, receptors can spontaneously open at very low probability (36-38), for 
simulation convenience it was assumed as initial condition, i.e. at t = 0, no bound or 
open receptors were present. The solution of such equations yielded the time courses 
of probabilities of all the states assumed in the model. The fit of the experimental data 
was performed by optimizing the values of rate constants. The procedure for the rate 
constants optimization was based on the comparison of the time course of recorded 
currents and that of simulated responses.  
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Results 
Delta and gamma2 subunit-containing GABAA receptors are clustered at 
extrasynaptic sites and become uniformly distributed after nocodazole treatment 
In the present work we analyzed the influence of the clustering of extrasynaptic 
GABAA receptors on tonic inhibition. Taking advantage of a previous demonstration 
that GABAA receptor clustering can be impaired by inducing the disassembly of the 
cytoskeleton with the microtubule disrupting drug nocodazole (27), we first analyzed 
the distribution pattern and nocodazole sensitivity of δ subunit-containing receptors. 
In fact there is a number of experimental evidence demonstrating that the δ subunit is 
exclusively expressed at extrasynaptic locations, even though, to our knowledge, its 
clustering has not been addressed yet.  
Immunocytochemical experiments were therefore performed in order to detect the 
surface distribution of δ subunit-containing receptors in untreated primary cultured 
hippocampal neurons. We interestingly found a clearly dotted staining of δ subunits 
(Fig. 1A). Delta subinits never colocalized with the presynaptic marker synaptophysin 
(Fig. 1B and C), thus suggesting a clustered arrangement of δ subunit-containing 
GABAA receptors at extrasynaptic sites. This punctate staining was significantly 
affected by nocodazole treatment. In fact, in nocodazole treated neurons, δ subunits 
were almost uniformly distributed along the cell surface although some residual 
puncta were still detectable (Fig. 1D, see inset).  The double staining 
delta/synaptophysin in nocodazole treated neurons never showed a colocalization of 
the two proteins, suggesting that also declustered δ-containing receptors maintained 
their extrasynaptic localization (Fig. 1F, see inset). 
Clusters of γ2 subunit-containing GABAA receptor have been recently identified at 
extrasynaptic sites (26, 39) although their functional role has been poorly 
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investigated. An antibody specific for the N-terminal extracellular domain of the γ2 
subunit was used to decorate γ2-containing GABAA receptors on the cell surface. In 
untreated neurons γ2 subunit displayed a punctate staining pattern over the neuronal 
somata and dendrites (Fig. 2A). Only some of the puncta were colocalized with 
synaptophysin, thus indicating that γ2 subunits are present both at synaptic (Fig. 2C, 
see open arrowheads) and extrasynaptic sites (Fig. 2C, see arrows). As expected from 
our previous work, nocodazole treatment was associated with the declusterization of 
γ2-subunit containing GABAA receptor (27). Most interestingly, we found that under 
these conditions colocalization between declustered γ2 subunits and synaptophysin 
was still detectable, thus indicating that nocodazole treatment affected both synaptic 
and extrasynaptic receptors (Fig. 2F, see crossed arrows).  
 
Tonic currents amplitude in untreated and nocodazole-treated neurons 
Currents were recorded from cultured hippocampal neurons in the whole-cell 
configuration of the patch-clamp technique at a holding potential of -70 mV in the 
presence of kynurenic acid (1 mM) and CGP 55845 (1 mM). In these conditions it 
was possible to record both sIPSCs and a persistent tonic current that was identified 
with the application of GABAA receptor antagonists (see Experimental Procedures). 
The application of bicuculline (100 µM) produced the complete disappearance of 
sIPSCs and an outward shift of the baseline current (Fig. 3A).  
In the attempt to test whether nocodazole treatment could affect the amplitude of the 
tonic current, the shift of the baseline current after the application of bicuculline (100 
µM) was measured in untreated and nocodazole-treated neurons. In these two 
conditions tonic currents were not significantly different. In untreated neurons the 
baseline shift was 14.7 ± 5.3 pA, while in nocodazole-treated neurons it was 12.7 ± 
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2.3 pA (n=6, p>0.05, Fig. 3 A and E). All-point histograms of the baseline current in 
untreated and nocodazole treated neurons exhibit overlapping distributions (Fig. 3B). 
Similar results were obtained with the application of picrotoxin (100 µM). The 
baseline shift was 15.4 ± 5.7 pA and 11.9 ± 3.5 pA in untreated and nocodazole-
treated neurons, respectively (data not shown, n=4, p>0.05). The similarity of the 
tonic current amplitude in untreated and nocodazole-treated neurons suggests that the 
depolymerization of microtubules and the associated declusterization of GABAA 
receptors did not reduce the number of the receptors expressed on the cell surface. 
This hypothesis is further supported by our previous demonstration that also the 
amplitude of synaptic currents and GABA-evoked currents was not significantly 
reduced after nocodazole treatment (27). 
 
Nocodazole treatment attenuates NO-711-induced increase of tonic current amplitude 
The lack of significant differences between tonic current amplitudes recorded in 
untreated and nocodazole-treated neurons could be attributed to the small 
concentration of ambient GABA mainly derived from spillover of the 
neurotransmitter from neighboring synapses. To test this hypothesis we sought to 
increase the concentration of ambient GABA by blocking GABA uptake with the 
GAT-1 antagonist, NO-711 (8, 34, 40, 41). In agreement with previous reports (34, 
41), NO-711 (100 µM) slowed down the deactivation kinetics of sIPSCs both in 
untreated and in nocodazole treated neurons. In untreated neurons the application of 
NO-711 increased the values of τmean from 24.1 ± 2.5 ms to 39.4 ± 4.8 ms (n=6, 
p<0.05, data not shown). Consistent with a larger concentration of ambient GABA, in 
the presence of NO-711 both untreated and nocodazole-treated neurons exhibited 
larger tonic currents (Fig. 3 C, D and E). In untreated neurons, after the application of 
 82
NO-711, the tonic current was ~3.6 fold larger than in control. In fact in NO-711 (10 
µM), the baseline shift induced by bicuculline was 51.5 ± 8.5 pA, while in control it 
was 14.7 ± 5.3 pA (p<0.001; n=6; Fig. 3 A, C and E). In contrast, in nocodazole-
treated neurons, NO-711 induced a non-significant increase in the amplitude of the 
tonic current, from 12.7 ± 2.3 pA to 22.9 ± 7.5 pA (p>0.05; n=6; Fig. 3 A, C and E). 
All point histogram of tonic currents recorded in the presence of NO-711, from 
untreated and nocodazole treated neurons clearly showed a significant difference in 
their distributions (p<0.001, Fig. 3D). In conclusion, in the presence of NO-711, the 
difference between the amplitude of the tonic current in untreated and in nocodazole-
treated neurons was statistically significant (p<0.05, Fig. 3E). 
 
Tonic currents from untreated and nocodazole-treated neurons are sensitive to 
flurazepam 
In order to compare the pharmacology of tonic currents in untreated and nocodazole-
treated neurons and to infer the subunit composition of extrasynaptic GABAA 
receptors, we studied the effect of benzodiazepines, known to be effective on γ2 
subunit-containing receptors (42, 43). 
The efficiency of FZP was assessed by analyzing its effect on the peak amplitude and 
the kinetics of sIPSCs. In agreement with previous studies (6, 44-46), in untreated 
neurons FZP (1 µM) significantly (p<0.05) prolonged the decay kinetics of sIPSCs 
(the value of τmean was 27.7 ± 2.1 ms in control and 33.9 ± 0.9 ms in FZP 1 µM; n=4) 
and increased their peak amplitude from 126.9 ± 26.2pA to 166.5 ± 28.9 pA (p<0.05; 
data not shown). The amplitude of the tonic current was measured in control 
conditions and during the application of FZP (1 µM and 3 µM). In untreated neurons 
FZP induced a significant dose-dependent increase of the amplitude of the tonic 
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current (from 14.4 ± 1.5 pA in control to 27.5 ± 2.5 pA in FZP 1 µM and to 36.3 ± 3.1 
pA in FZP 3 µM; p<0.001; n=6; Fig. 4). After nocodazole treatment the effect of FZP 
was attenuated. The mean amplitudes of tonic current increased from 11.6 ± 2.1 pA in 
control to 17.6 ± 3.4 pA and 22.9 ± 3.5 pA, in FZP 1 µM and 3 µM, respectively 
(n=6; p<0.02; Fig. 4). It is clear from Fig. 4 that all point histograms of tonic current 
amplitudes recorded in control conditions from untreated and nocodazole-treated 
neurons show two overlapping distributions (p>0.05; Fig. 4B), while those recorded in 
the presence of FZP (3 µM) are significantly separated (p<0.01; Fig. 4C). The 
susceptibility of tonic currents to benzodiazepines suggests the involvement of γ2 
subunit-containing receptors.  
 
Nocodazole treatment reduces the amplitude of tonic currents induced by low 
concentrations of exogenous GABA 
A widely accepted hypothesis is that the spillover of GABA from neighboring 
synapses contributes to the accumulation of the neurotransmitter in the extracellular 
space (1, 3, 32), thus influencing tonic inhibition. A direct proof of an activity-
dependent modulation of tonic currents came from experiments performed in the 
presence of TTX where reduced synaptic activity was accompanied with a tonic 
current of smaller amplitude (45, 47). In a set of experiments TTX (1 µM) was added 
to the external solution in addition to kynurenic acid (1 mM) and CGP 55845 (1 mM). 
In these conditions the amplitudes of the tonic current were 7.5 ± 1.2 pA and 7.8 ± 3.3 
pA (n=12-14; Fig. 5A), in untreated and nocodazole-treated neurons, respectively, i.e. 
~ two fold smaller than in the absence of TTX (see Fig. 3A). Similar results were 
obtained when picrotoxin (8) was used instead of bicuculline. In the presence of TTX 
the amplitudes of the tonic current were 7.7 ± 3.2 pA and 7.2 ± 3.7 pA in untreated 
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and nocodazole-treated neurons, respectively (n=4, data not shown). These results 
clearly indicate a direct correlation between synaptic activity and tonic current 
amplitude.  
In order to quantitatively estimate the correlation between the concentration of GABA 
in the extracellular space and the amplitude of the tonic current in untreated and 
nocodazole-treated neurons, low concentrations of GABA (0.1 – 1 µM) were applied. 
In this set of experiments TTX (1 µM) was added to the external solution in order to 
minimize the amount of endogenously released GABA. In both untreated and 
nocodazole-treated neurons, GABA produced a dose-dependent downward shift of the 
baseline current. (Fig. 5 A and C). 
However, in nocodazole-treated neurons this effect was less pronounced and the 
amplitude of the tonic current induced by a given concentration of GABA was always 
smaller than the corresponding value in untreated neurons. In particular, the 
difference became significant at GABA (1 µM). In untreated and nocodazole-treated 
neurons the amplitudes of the current were 134.7 ± 17.1 pA and 87.3 ± 9.8 pA, 
respectively (p<0.05, n = 12-14, Fig. 5C). The all-point histograms of the tonic 
current in the presence of GABA 1 µM showed distinct distributions with 
significantly different mean and standard deviation values (Fig. 5B). 
In order to see whether nocodazole-induced reduction in amplitude of tonic currents 
could be attributed to changes in the single channel conductance of declustered 
receptors, a simplified form of stationary variance analysis of the baseline currents 
was performed (6, 32, 34, 35). The single channel conductance of clustered and 
declustered receptors was calculated assuming that the concentration of GABA 
responsible for tonic current is so low that the receptor open probability becomes 
negligible. The relationship between the amplitude (I) and the variance (σ2) of the 
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tonic current is illustrated in Fig. 5D. As shown in the Figure 5D the estimated single 
channel conductance of GABAA receptors exposed to 0.1 - 1 µM GABA in untreated 
and nocodazole-treated neurons were comparable (17.1 ± 1.0 pS and 16.6 ± 2.5 pS, 
respectively, p>0.05, n=12-14). These data allow excluding nocodazole-induced 
changes in single channel conductance or re-assortment of GABAA receptor subunits 
exhibiting different conductances. 
Interestingly, the dose-dependent increase in the amplitude of the tonic current 
induced by exogenous GABA, was accompanied with a similar increase of the SD of 
the baseline current (Fig 6A). The S.D. has been considered a good parameter for 
evaluating the variability of the tonic current since it reflects the level of activation of 
GABAA receptors (6, 8, 35).  
The S.D. of the tonic currents in control and in the presence of low [GABA] was 
normalized to that obtained in the presence of bicuculline. In nocodazole-treated 
neurons these values were always smaller than in untreated neurons (Fig. 6A). In 
particular, when GABA 1 µM was applied, the normalized S.D. of the tonic current in 
nocodazole-treated neurons was significantly smaller than that observed in untreated 
ones (1.9 ± 0.1 and 2.5 ± 0.2, respectively, n=12-16, p<0.05). This result suggests 
that, in response to the same GABA concentration, GABAA receptors are less 
activated after nocodazole treatment. 
A further confirmation of this hypothesis came from the measurement of the 
membrane input resistance in untreated and nocodazole-treated neurons. The input 
resistance values obtained in the presence of bicuculline or low [GABA] were 
normalized to those found in control conditions (Fig. 6B). In bicuculline the 
normalized value was similar in untreated and in nocodazole-treated neurons (1.05 ± 
0.04 and 1.12 ± 0.03, respectively, n= 6, p>0.05), and, as expected, greater than 1. At 
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increasing concentrations of GABA, the normalized input resistance progressively 
decreased, reflecting a larger flow of ions through the receptors i.e. a larger shunting 
inhibition. However in nocodazole-treated neurons this effect was less pronounced 
and in the presence of GABA 1 µM the normalized input resistance was significantly 
larger than in untreated ones (0.45 ± 0.04 and 0.59 ± 0.08 in untreated and 
nocodazole-treated cells, respectively, n=6, p<0.05). 
 
The block of GABA-evoked currents induced by a prolonged exposure to low [GABA] 
is smaller after nocodazole treatment 
The reduction of tonic inhibition observed in nocodazole-treated neurons can be 
attributed either to a change in the gating properties of GABAA receptors or to a 
reduced number of receptor channels.  To test for these possibilities, currents evoked 
by ultrafast applications of saturating [GABA], after a pre-equilibrating protocol with 
low [GABA] or with a control solution, both in untreated and nocodazole-treated 
neurons were examined. 
If nocodazole treatment per se reduced the number of active receptors, all the 
responses, with and without pre-equilibration with low [GABA], should be smaller 
than those obtained in untreated neurons. The peak amplitude of the currents evoked 
by saturating [GABA] after nocodazole treatment was used as an index of the total 
number of functional declustered GABAA receptors. 
Currents were recorded at –30 mV from nucleated patches. GABA pulses (10 mM for 
2 ms) were applied every 2 minutes either in control or after 20’’ pre-equilibration 
with low [GABA] (0.3 – 1 µM). Only stable recordings with no signs of run down 
were used for the analysis. The responses obtained in control and after pre-
equilibration with low [GABA] were averaged separately. The responses evoked by 
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saturating [GABA] in untreated and nocodazole-treated neurons in control conditions 
(without pre-equilibration with low [GABA] were very similar (1056.6 ± 144.3 pA 
and 1010.5 ± 212.2 pA, respectively, n=10-11, p>0.05, Fig. 7A). This suggests that 
nocodazole treatment does not affect the number of active receptors (see ref. 27). 
After the pre-equilibrating protocol with GABA (1 µM), the amplitude of the 
responses elicited by saturating pulses of GABA (10 mM) was significantly reduced. 
However, in comparison with untreated neurons, the responses obtained after 
nocodazole treatment were significantly smaller (240.2 ± 30.2 pA and 136.8 ± 47.9 
pA in untreated and nocodazole-treated neurons, respectively; n=10-11; p<0.05; Fig. 
7A). This indicates that pre-equilibration with GABA produces a block of GABA 
responses of 70.7 ± 4.3 % and 86.1 ± 2.3 % of GABA in untreated and nocodazole-
treated neurons, respectively (p<0.05, Fig. 7B). 
In the presence of GABA (0.3 µM) the reduction in the peak amplitude of GABA-
evoked currents in untreated and nocodazole-treated neurons was significantly 
different (37.2 ± 3.3 % and 51.3 ± 3.4 %, respectively; n=10-11; p< 0.05; Fig. 7B). In 
conclusion, the pre-equilibration of nucleated patches with low [GABA] blocked 
more extensively GABA-evoked currents in nocodazole-treated neurons than in 
untreated ones. 
 
Model simulations 
The present findings demonstrate that in cultured hippocampal neurons, nocodazole-
induced microtubule disruption is associated with the declusterization of extrasynaptic 
GABAA receptors and with a reduction of tonic inhibition. In particular, after 
nocodazole treatment, declustered extrasynaptic GABAA receptors are less activated 
by ambient (endogenous or exogenous) GABA, thus the amplitude of the tonic 
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current is smaller. In the attempt to reconstruct the gating properties of declustered 
extrasynaptic GABAA receptors, model simulations were used. We referred to the 
kinetic model proposed by Jones and Westbrook (48) (Fig. 8A), which fulfils the 
minimum requirement to adequately reproduce the gating of GABAA receptors in 
different experimental protocols. We adopted and optimized the parameters we 
proposed previously (27) to reproduce the gating properties of declustered synaptic 
GABAA receptors. Since the concentrations of GABA used in that study were >30 
µM, the transitions between singly-bound open and desensitized states could not be 
resolved (49, 50). Therefore the corresponding rate constants were merely adopted 
from Jones and Westbrook (48). In the present work the application of extremely low 
concentrations of GABA (0.1-1 µM) allowed investigating the singly bound states 
(50-52). The rate constants were adjusted in order to reproduce tonic and GABA-
evoked currents recorded in the presence of exogenous GABA. The experimental data 
and our previous study (27) suggested that declustered receptors can be more 
susceptible to desensitization. For this reason in this study we tried to simulate an 
increased occupancy of the singly-bound desensitized state, besides the already 
assessed larger occupancy of the doubly-bound desensitized state (27). It must be 
pointed out that a larger occupancy of a given conformational state may be either due 
to a faster entry into or a slower exit from that state. Unfortunately for the singly 
bound states there are no specific protocols to distinguish between these two 
possibilities. For this reason we achieved a simulated larger occupancy of the singly-
bound desensitized state of declustered receptors, simply by increasing the value of 
d1, the rate constant governing the transition from the singly-bound closed states to 
the singly-bound desensitized state (Fig. 8B). 
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With the increased value of d1 it was possible to reproduce the smaller amplitude of 
tonic current in nocodazole-treated neurons (Fig. 8C). During a simulated prolonged 
(10 s) exposure to GABA (1 µM and 0.3 µM) the steady state open probability (tonic 
current) of declustered GABAA receptors was 0.0034 and 0.0031, respectively, while 
that of clustered receptors was 0.0094 and 0.0047, respectively. Such small values 
indicate that when GABA is present in the extracellular space (ambient GABA), the 
open states of GABAA receptors are poorly occupied. Nevertheless after nocodazole 
treatment their occupancy is even smaller. 
The same sets of rate constants relative to clustered and declustered receptors were 
used to simulate GABA-evoked currents in control and after pre-equilibration with 
GABA containing solutions. The reduction of the simulated open probability induced 
by pre-equilibration with low [GABA] was very similar to that recorded 
experimentally. Simulated pre-equilibration with GABA (1 µM) induced a block of 
71% and 84% (Fig. 8E) while with GABA (0.3 µM) induced a block of 42% and 61 
% for clustered and declustered GABAA receptors, respectively (Fig. 8D).  
Model simulations suggest that after nocodazole treatment there is a larger occupancy 
of the singly bound desensitized state of GABAA receptors and this is responsible for 
reduced tonic inhibition. 
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Discussion 
The present results clearly demonstrate that, in cultured hippocampal neurons, 
nocodazole treatment induces the declusterization of extrasynaptic GABAA receptors, 
and reduces GABA-mediated tonic inhibition. Analysis of GABA-evoked currents 
after pre-incubation with low concentrations of GABA and model simulations suggest 
that the effects of nocodazole on tonic inhibition are mainly due to changes in the 
gating properties of GABAA receptors. In particular we propose that nocodazole 
treatment promotes the accumulation of declustered receptors into singly bound 
desensitized state during tonic exposure to ambient GABA.  
Consistent with previous reports (20, 25, 26, 39, 53) our immunocytochemical data 
clearly demonstrate that, in addition to synaptic receptors, also extrasynaptic ones are 
arranged in clusters, and that they become uniformly distributed throughout the cell 
surface after nocodazole treatment. In agreement with other groups we have found 
that extrasynaptic receptors in the hippocampus include the δ and the γ2 subunit (39, 
54-56). However it seems quite clear that the δ and the γ2 subunits cannot be 
assembled within the same receptor (57, 58). Yet, the exact subunit composition of 
extrasynaptic GABAA receptors is still unknown although a substantial effort has been 
recently made in this direction (58-60). While the contribution of δ subunits has been 
well documented particularly in the dentate gyrus (55, 56), that of γ2 subunits has 
been often neglected (20, 61). The lack of complete disappearance of the tonic current 
in the hippocampus of δ-/- mice favored the involvement of other receptor subunits 
(15, 62). Possible candidates are the γ2 subunits since they are required for the 
observed facilitatory effect of FZP on tonic inhibition (42, 43, 63-66). However it 
must be pointed out that BDZ sensitivity can also be due to α5 subunit containing 
receptors (67-69) that are largely expressed in the hippocampus (68-71). On the basis 
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of recent studies that have demonstrated the co-assembly of α5 and γ2 subunits and 
have predicted that native receptors in the hippocampus were α5β3γ2 (68, 71), we can 
speculate that in our preparation γ2 subunits may belong to α5β3γ2 receptors.  
In the present experiments nocodazole was used as a pharmacological tool to promote 
the loss of clustered arrangement of GABAA receptors. The observation that, after 
nocodazole treatment, the declusterization of receptors that did not co-localise with 
synaptophysin (i.e. extrasynaptic receptors) was associated with changes in tonic 
inhibition suggests that the two events are correlated. Although nocodazole-treatment 
affected both synaptic and extrasynaptic receptors, it is conceivable that the 
contribution of synaptic receptors to tonic currents is very small or even negligible, 
since the number of extrasynaptic receptors largely exceeds that of synaptic ones (24, 
72).   
By comparing the amplitude of tonic currents evoked by endogenous or exogenous 
applications of GABA it was possible to estimate the ambient agonist concentration in 
our preparation. Consistent with previous reports on cerebellar granule cells (45) and 
cultured hippocampal neurons (73) we found a value ~ 0.1 µM. However, these 
estimations, may not exactly reflect the physiological value in vivo since they all refer 
to neurons in culture. In fact the loss of the anatomical arrangement and the 
modification of the architecture of the extracellular space in primary cultures may 
influence the concentration of ambient GABA.  In our results differences between 
tonic inhibition mediated by clustered and declustered receptors could be revealed 
only when ambient GABA was increased (i.e. in the presence of NO-711 or at the 
highest concentration of exogenous of GABA). This evidence suggests that, in normal 
conditions, the modulatory effect of receptor clustering on tonic inhibition is not 
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detectable, but it becomes effective when ambient [GABA] exceeds a threshold as 
during sustained GABAergic activity. 
Noise analysis has demonstrated that in both untreated and nocodazole treated 
neurons “low conductance channels” mediate tonic inhibition. The value of the single 
channel conductance estimated here for both clustered and declustered receptors (~16 
pS) is consistent with that reported previously (32, 45, 49-51, 74) for receptors 
mediating tonic inhibition  (74, 75). It has been proposed that receptors can be 
partially or fully activated depending on the concentration of agonist they “see” (76-
78). Therefore, it is possible that, at ambient concentrations of GABA, tonic currents 
are mainly mediated by monoliganded receptors in a lower conductance state (6, 35, 
50). However, it cannot be excluded that the conductance level of a given receptor can 
be also influenced by its subunit composition (45, 69, 74). Therefore the comparable 
estimation of the single channel conductance of clustered and declustered receptors 
suggests that, at low concentrations of agonist, the receptors are similarly activated 
since nocodazole treatment affects neither the molecular structure/subunit 
composition nor the proportion of monoliganded GABAA receptors.  
The widespread action of nocodazole raises the possibility that modulation of tonic 
inhibition can be due to multiple indirect effects. For instance it is possible that this 
drug alters the release machinery and therefore influences the concentration of 
ambient GABA, or reduces the number of GABAA receptors, changes their subunit 
composition or affects their gating properties. On the basis of our previous work (27) 
we can exclude a presynaptic site of action of nocodazole since this drug did not 
affect the frequency of mIPSCs and comparable results were obtained when 
nocodazole was added either to the culture medium or to the intracellular solution. 
The similar effect of nocodazole on tonic currents induced by endogenous and 
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exogenous applications of low concentrations of GABA argues against a reduction of 
ambient GABA. As previously discussed, we believe that nocodazole did not modify 
the number of GABAA receptor on the cell surface since the peak amplitudes of tonic 
and GABA-evoked currents were comparable in untreated and nocodazole-treated 
neurons (see also ref. 27). The similar single channel conductance estimated for 
clustered and declustered receptors allows excluding a re-assorted subunit 
composition of GABAA receptors after nocodazole treatment. In conclusion, we 
believe that the effect of nocodazole on tonic inhibition is due to changes in the gating 
properties of declustered GABAA receptors. This idea is supported by the results from 
the pre-equilibrating protocols combined with kinetic modelling and computer 
simulations.  
Previous studies have demonstrated that pre-equilibration of excised patches with 
micromolar or submicromolar concentrations of agonist, trapped the receptors in slow 
and strongly absorbing desensitized states (41, 52, 79, 80). In the present work it was 
found that the reduction of current responses to saturating [GABA] after pre-
equilibration with low [GABA] was larger in nocodazole-treated neurons than in 
untreated ones. This suggests a larger occupancy of slow desensitized states of 
declustered GABAA receptors, presumably in the singly bound conformation. For this 
reason, the kinetic model previously proposed to reproduce the gating of declustered 
receptors (27) was optimised taking into account the experimental data obtained with 
extremely low [GABA]. In fact it is widely accepted that the probability of occupancy 
of the receptors in the singly bound conformation is relevant only at very low 
concentrations of GABA (≤10 µM), while it can be neglected at saturating or 
subsaturating concentrations of agonist (50-52). It is for this reason that the increased 
occupancy of the singly bound desensitized state of declustered receptors allows 
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mimicking the effect of nocodazole on tonic currents and the results of the pre-
equilibration experiments. It is worth noting that the parameters used in the present 
work did not alter the simulations of previous results on mIPSCs and GABA-evoked 
currents (27). However the lack of specific protocols to selectively unmask the 
kinetics of the singly bound states allows only a qualitative estimation. In fact we 
cannot precisely attribute the larger occupancy of the singly bound desensitized 
conformation to an increased rate of entry or to a decreased rate of exit from that 
state. Nevertheless we cannot exclude the possibility that also slowly absorbing 
doubly bound desensitized states (81, 82) neglected in the Jones and Westbrook’s 
model can also be involved.  
We conclude that desensitization of GABAA receptor, in particular of extrasynaptic γ2 
containing ones, contributes to the modulation of tonic inhibition. This conclusion is 
supported by the data reported previously (82) demonstrating that the significant but 
still incomplete desensitization of γ2-containing receptors allows a current amplitude 
comparable to that mediated by low desensitizing δ−containing receptors. Moreover 
less apparent desensitization is observed in γ2 currents evoked by low agonist 
concentrations (79, 81). 
The present work suggests that receptor clustering is an additional regulating factor 
for tonic inhibition. Since clustered extrasynaptic GABAA receptors mediate larger 
tonic currents, it is possible that either in physiological and pathological conditions 
receptor clustering can modulate tonic inhibition and in turn influence synaptic 
efficacy and integration (6, 10, 13, 14, 20).  
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Figure legends  
FIG. 1 Extrasynaptic clusters of δ subunit-containing GABAA receptors are lost 
after nocodazole treatment 
Neurons were labeled with a polyclonal antibody recognizing GABAA receptor δ 
subunit (green), in combination with a mouse anti-synaptophysin antibody (red). In 
untreated neurons, δ subunit-containing GABAA receptors were arranged in clusters 
(A) localized exclusively at extrasynaptic sites, since they were never associated with 
synaptophysin immunoreactivity (B and C). After nocodazole treatment δ subunit-
containing GABAA receptors were uniformly distributed (D) and they still did not 
overlap with synaptophysin staining  (E and F) Lower panels are magnifications of 
the boxed windows. Panels scale bar, 10 µm; insets scale bar, 20 µm. 
  
FIG. 2 Nocodazole treatment promotes the disassembly of γ2 subunit-containing 
GABAA receptors clusters located both at synaptic and extrasynaptic sites  
Neurons were labeled with a rabbit polyclonal antibody specifically recognizing 
GABAA receptor γ2 subunit (green) in combination with mouse anti-synaptophysin 
(red). Lower panels are magnification of the boxed windows. In untreated neurons (A-
C) γ2 subunit-containing GABAA receptors formed clusters, that either colocalized 
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with synaptophysin immunoreactivity (synaptic clusters, open arrowheads) or not 
(extrasynaptic receptors, arrows). Nocodazole treated neurons (D-F) displayed a 
diffuse γ2-subunit immunoreactivity throughout the cell surface. However some 
residual puncta could be still detected. Note that some diffuse γ2 subunit-containing 
GABAA receptors still colocalized with synaptophysin indicating synaptic receptors 
(crossed-arrows). Panels scare bar, 20 µm; insets scale bar, 10 µm. 
 
FIG. 3 Nocodazole attenuates the effect of NO-711 on tonic current amplitudes 
A, Currents (lower traces) recorded in control conditions and in the presence of 
bicuculline (upper lines) from untreated (left panel) and nocodazole-treated neurons 
(right panel). Some sIPSCs were present, but they were excluded from the analysis of 
tonic current amplitudes. The dotted line represents the holding current in the 
presence of bicuculline. B, All point histogram of a 500 ms trace recorded in control 
conditions from untreated and nocodazole-treated neurons (note that the two 
distributions overlap) and in the presence of bicuculline. The thin black lines 
represent the gaussian fit of the distributions. C, Tonic currents (lower traces) 
recorded in the presence of NO-711 and in the presence of bicuculline (upper lines) 
from untreated (left panel) and nocodazole-treated neurons (right panel). D, All point 
histogram of a 500 ms trace recorded in the presence of NO-711 from untreated and 
nocodazole-treated neurons (note that the two distributions are significantly shifted) 
and in the presence of bicuculline. E, Summary of the mean tonic current amplitude 
(baseline shift) in control and in the NO-711, for untreated and nocodazole-treated 
neurons (n=6). *, p<0.05. 
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FIG. 4 Nocodazole treatment reduces the enhancing effect of FZP on tonic 
currents 
A, Example traces recorded from untreated (left panel) and nocodazole-treated (right 
panel) neurons in control conditions, in the presence of FZP (1 and 3 µM) and 
bicuculline (upper lines). The dotted lines represent the holding current in the 
presence of bicuculline. sIPSCs were removed during the analysis of tonic currents. B, 
All point histogram of 500 ms trace recorded in control conditions from untreated and 
nocodazole-treated neurons (note that the two distributions overlap) and in the 
presence of bicuculline. The thin black lines represent the gaussian fit of the 
distributions. C, Similar all point histogram, in the presence of FZP 3 µM. Note the 
different distributions between untreated and nocodazole-treated neurons. D, Mean 
tonic current amplitude recorded from untreated and nocodazole-treated neurons in 
control and in the presence of FZP (1 and 3 µM), n=6. *, p<0.05. 
 
FIG. 5 In nocodazole-treated neurons tonic currents evoked by exogenous 
applications of low [GABA] are smaller  
A, Currents recorded in control conditions and in the presence of different 
concentrations of exogenous GABA from untreated (left panel) and nocodazole-
treated neurons (right panel). The holding current in the presence of bicuculline sets 
the zero level and it is represented by the dotted line. B, All point histogram of 500 ms 
trace recorded in the presence of GABA 1 µM and bicuculline from untreated and 
nocodazole-treated neurons. mIPSCs were excluded from the analysis. C, Mean 
amplitude of tonic currents recorded in control and in the presence of different 
concentrations of GABA from untreated and nocodazole-treated neurons. (n=12-14). 
*, p<0.05. D, Plots of the variance vs the amplitude of the tonic currents recorded 
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from untreated (left panel) and nocodazole-treated (right panel) neurons (n=12-14). 
The solid lines is the linear regression fits of the all data points. The estimated mean 
single channel conductance was ~16 pS for untreated and nocodazole-treated neurons. 
 
FIG. 6 After nocodazole treatment GABAA receptors are less activated in 
response to low agonist concentrations 
A, Mean standard deviation of baseline currents recorded in control and in the 
presence of low [GABA], normalized to that recorded in the presence of bicuculline 
(n=12-14). *,p<0.05. B, Mean membrane input resistance recorded from untreated and 
nocodazole-treated neurons in the presence of bicuculline and low [GABA], 
normalized to the value recorded in control (n=6). *, p<0.05. 
 
FIG. 7 The block of GABA-evoked currents after pre-equilibration with low 
[GABA] is larger in nocodazole-treated neurons 
A, Current responses to short pulses (2 ms) of saturating GABA (10 mM, open bars) 
after 20’’ pre-equilibration with a control solution (thick line) or with GABA 1 µM 
(thin line) in untreated (left panel) and nocodazole-treated (right panel) neurons. B, 
Mean reduction of control responses after the pre-equilibration with low [GABA], in 
untreated and nocodazole-treated neurons  (n=10-11). *, p<0.05 
 
FIG.  8 Model simulations 
A, Kinetic model proposed by Jones and Westbrook (48). According to the model the 
receptor (R) can bind one or two molecules of agonist (A), reaching either the singly 
(AR) or doubly-bound-closed state (A2R). From these states it can open (AR*  and 
A2R*) or desensitize (AD and A2D). B, Values of the rate constants chosen to 
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simulate tonic and GABA-evoked currents in control and nocodazole. C, Simulated 
tonic current (lower traces) evoked by a prolonged exposure to GABA 1 µM (upper 
lines) in untreated and nocodazole-treated neurons. D, Mean reduction of the 
amplitude of simulated GABA-evoked currents after pre-equilibration with low 
[GABA] in untreated and nocodazole-treated neurons. E, Simulated current responses 
(lower traces) to short pulses (2 ms) of saturating GABA (10 mM, open bar) after 
pre-equilibration with a control solution (thick line) or with GABA 1 µM (thin line) in 
untreated (left panel) and nocodazole-treated (right panel) neurons. 
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5. Conclusions and future perspectives 
In this thesis I have analyzed the heterogeneity of phasic and tonic GABAergic 
inhibition in cultured hippocampal neurons, as a result of the presynaptic variability 
of GABA transient in the cleft and of the postsynaptic modulation of the gating 
properties of GABAA receptors induced by receptor clustering.  
The heterogeneity of spontaneous miniature GABA-mediated synaptic currents is 
exemplified by the broad and skewed distribution of amplitudes of mIPSCs. At non-
saturated synapses I found that the variability of synaptic currents was correlated with 
the variability of GABA concentration profile in the cleft. In particular both the 
concentration GABA (At) that activates the receptors and the speed of clearance of the 
agonist from the cleft (τt) are crucial for determining the amplitude and kinetics of 
synaptic currents. By modeling mIPSCs it was possible to find out a range of 
variability for At and τt values responsible for the observed mIPSCs variability. 
According to the estimation reported in this thesis, rapidly cleared low concentrations 
of GABA in the cleft are responsible for small and rapid mIPSCs, while large and 
persistent concentrations of agonist in the cleft elicit large and slow synaptic events. 
Probably the most innovative result reported in this thesis is the identification of 
GABAA receptor clustering as a novel possibility for the modulation of GABAergic 
transmission. In fact an accurate analysis of the influence of GABAA receptor 
clustering on phasic and tonic GABA-mediated inhibition has never been reported 
previously. The only previous attempt in this direction was made by Chen et al. 
(2000) who described altered kinetic properties of GABA-evoked currents mediated 
by declusterered recombinant receptors. As pointed out by the authors, the 
overexpression of the receptors in a heterologous system was far from approaching 
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physiological conditions. Moreover the limited time resolution of the agonist 
application system precluded the assessment of the kinetic changes occurring at 
submillisecond time scale.   
In our preparation, i.e. cultured hippocampal neurons, the microtubule 
depolymerizing drug nocodazole proved to be a useful tool to induce the disruption of 
GABAA receptor clusters. Therefore it was possible to record changes in both phasic 
and tonic currents after nocodazole treatment. The combination of an ultra-fast 
agonist perfusion system and model simulations allowed concluding that receptor 
clustering affects the gating properties of GABAA receptors. In particular the 
desensitization of the receptors in the singly and doubly-bound conformations 
appeared to be promoted in declustered receptors. Nevertheless we cannot exclude the 
possibility that receptor clustering may also affect slowly absorbing doubly bound 
desensitized states (Haas & Macdonald, 1999; Bianchi et al., 2002) neglected in our 
model. It is worth noting that these conclusions came from separate investigations on 
GABA-evoked responses mimicking phasic and tonic currents. In fact the study of 
currents evoked by GABA concentrations larger than 30 µM shed light only on the 
transitions within the doubly-bound open and desensitized states, while the effects of 
the persistent exposure to submicromolar concentrations of agonists allowed resolving 
the singly bound conformations. Regardless the number of desensitized states 
involved, the conclusions reported here are in line with the recently reported crucial 
role of receptor desensitization in shaping GABAA mediated currents (Mozrzymas et 
al., 2003b). In fact the different conformational states of the receptors follow a 
Markovian scheme and this inherently implies that the temporal profile of the 
occupancy of any conformation depends on all the rate constants and occupancies of 
all other states.  
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Immunocytochemical approaches have shown that γ2 subunit-containing receptors are 
present not only at synaptic but also at extrasynaptic sites, therefore supporting 
electrophysiological evidence for the possible involvement of this receptor subtype in 
mediating tonic inhibition. Both γ2 and δ subunit-containing receptors (the latter found 
exclusively at extrasynaptic locations) are arranged in clusters and are sensitive to 
nocodazole.  
Although at first choice nocodazole provided a decent tool to induce the 
declusterization of GABAA receptors, it should be used with caution. In fact 
microtubules are widespread throughout the neurons and are involved in many 
physiological processes. Therefore, in addition to the declusterization of GABAA 
receptors, microtubule disruption might have provided possible bias by promoting any 
other kind of effect. Although all the electrophysiological results collected from 
declustered receptors with different techniques seem to be coherent, we have been 
always aware of this weakness. 
It is for this reason that a promising ongoing collaboration with Prof. Cattaneo’s 
group is aiming at selecting specific tools for inducing GABAA receptors 
declusterization by taking advantage of a robust procedure they have developed, 
called Intracellular Antibody Capture Technology (IACT) (Visintin et al., 2002). The 
rationale is to ablate proteins’ function by taking advantage of antibody specificity in 
recognizing antigens, i.e. intracellular immunization (Biocca & Cattaneo, 1995). 
However it is worth noting that when antibodies are expressed in the cell cytoplasm, 
folding and stability problems often occur. The reducing condition of the cytoplasm 
(Hwang et al., 1992) hinders the formation of the intradomain disulphide bond in the 
VH and VL domains (Biocca & Cattaneo, 1995), resulting in low expression levels and 
limited half-life of antibody domains. However, some single-chain Fv (scFv), which 
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consist of a VH chain linked to a VL chain, have been shown to tolerate the absence of 
this bond (Proba et al., 1997) and to maintain their function when overexpressed in 
cells. 
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Fig.1 Schematic representation of the structure of IgG and scFv 
 
The impairing effect of these scFv on the function of a target protein can be achieved 
in two different ways. One possibility is the steric hindrance of scFv that prevents the 
interaction of the target protein with other molecules. Another possible mechanism is 
that engineered scFv change the localization of the target protein. For instance an 
scFv modified with a nuclear localization sequence would first bind the target protein 
and then redirect and retain it into the nucleus. 
The selection strategy for functional scFv (IACT) occurs in vivo and is based on a 
two-hybrid approach (Visintin et al., 1999).  
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 Fig.2 Diagram of the two hybrid-based IACT approach (from Visintin et al., PNAS, 1999 ) 
 
Briefly the two-hybrid system is adapted to detect antibody-antigen interaction in 
vivo. Yeast expression constructs are prepared encoding either an antibody fragment, 
in the form of scFv, linked to the VP16 transcriptional activation domain (AD) or the 
LexA DNA binding domain (DBD) linked to an target antigen sequence (bait). These 
constructs are cotransfected into yeast cells unable to synthesize histidine and 
carrying either the histidine (his) gene or the lacZ gene controlled by a minimal 
transcription promoter with a LexA DNA binding site (DBS). If antibody-bait 
interaction occurs in vivo, the resulting complex can bind to the LexA DBS upstream 
of his or lacZ genes and transcription of these genes occurs (the VP16 activation 
domain is thus brought close to the DNA transcription start site and can recruit 
accessory factors needed for transcription). The transcriptional activation of the his 
gene facilitates growth of yeast in growth media lacking histidine and activation of 
the lacZ gene produces β-gal, which can be assayed with 5-bromo-4-chloro-3-indolyl 
β-D-galactoside to yield blue yeast colonies. Neither feature of the transfected yeast 
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will occur if the antibody fragment does not functional inside cells. Once the positive 
scFvs have been isolated, their specific interaction with the bait protein is confirmed 
again both in yeast and in vitro. Then the ability of maintaining appropriate folding is 
verified in mammalian cells and finally scFvs must be functionally tested for their 
ability to impair the function of the bait protein. 
In the attempt to select specific tools for studying GABAA receptor clustering two 
different proteins involved in receptor trafficking and/or clustering (GABARAP and 
gephyrin) have been used as baits for the IACT approach. Untill now scFv 
specifically recognizing GABARAP and gephyrin have been already selected and 
their interaction with these two bait proteins confirmed. Moreover successful 
expression of anti gephyrin scFv has been detected in both neuronal and non-neuronal 
cells. 
 
 
                   
 
Fig.3 Immunofluorescence microscopy of anti-gephyrin-FLAG scFv transiently trasnfected in COS 
cells (non neuronal type), incubated with an anti-FLAG primary antibody and a FITC-conjugated 
secondary antibody. 
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Fig.4 Immunofluorescence microscopy of anti-gephyrin-FLAG scFv transiently trasnfected inprimary 
cultured hippcampal neturons, incubated with an anti-FLAG primary antibody and a FITC-conjugated 
secondary antibody. 
                  
Anti-GABARAP and anti-gephyrin scFv will be tested on neurons soon for their 
ability to induce the declusterization of native GABAA receptors. 
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